Frequencies for first 10,000 rows of pt variable in reac2018q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal adhesions | 1 0.01 0.01 Abdominal discomfort | 23 0.23 0.24 Abdominal distension | 8 0.08 0.32 Abdominal hernia | 1 0.01 0.33 Abdominal migraine | 1 0.01 0.34 Abdominal pain | 32 0.32 0.66 Abdominal pain lower | 9 0.09 0.75 Abdominal pain upper | 31 0.31 1.06 Abdominal wall infection | 1 0.01 1.07 Abnormal behaviour | 10 0.10 1.17 Abnormal dreams | 1 0.01 1.18 Abnormal weight gain | 3 0.03 1.21 Abnormal withdrawal bleeding | 1 0.01 1.22 Abortion induced | 3 0.03 1.25 Abortion spontaneous | 13 0.13 1.38 Abortion threatened | 1 0.01 1.39 Abscess | 3 0.03 1.42 Acanthosis | 1 0.01 1.43 Acanthosis nigricans | 2 0.02 1.45 Accident | 4 0.04 1.49 Accidental exposure to product | 2 0.02 1.51 Acinetobacter infection | 1 0.01 1.52 Acne | 11 0.11 1.63 Acquired diaphragmatic eventration | 1 0.01 1.64 Acquired haemophilia | 2 0.02 1.66 Acquired syringomyelia | 1 0.01 1.67 Actinic elastosis | 2 0.02 1.69 Actinic keratosis | 1 0.01 1.70 Actinomycosis | 2 0.02 1.72 Acute coronary syndrome | 3 0.03 1.75 Acute generalised exanthematous pustu.. | 3 0.03 1.78 Acute graft versus host disease | 1 0.01 1.79 Acute graft versus host disease in skin | 1 0.01 1.80 Acute hepatic failure | 7 0.07 1.87 Acute kidney injury | 33 0.33 2.20 Acute lymphocytic leukaemia | 2 0.02 2.22 Acute myeloid leukaemia | 6 0.06 2.28 Acute myocardial infarction | 9 0.09 2.37 Acute pulmonary oedema | 3 0.03 2.40 Acute respiratory distress syndrome | 3 0.03 2.43 Acute respiratory failure | 4 0.04 2.47 Acute sinusitis | 2 0.02 2.49 Adenocarcinoma gastric | 1 0.01 2.50 Adenocarcinoma of colon | 1 0.01 2.51 Adenoid cystic carcinoma | 1 0.01 2.52 Adenoidal disorder | 1 0.01 2.53 Adenoidectomy | 2 0.02 2.55 Adenotonsillectomy | 1 0.01 2.56 Adhesiolysis | 1 0.01 2.57 Adipomastia | 2 0.02 2.59 Adjustment disorder with depressed mood | 1 0.01 2.60 Adjustment disorder with mixed anxiet.. | 1 0.01 2.61 Administration site reaction | 1 0.01 2.62 Adrenal insufficiency | 2 0.02 2.64 Adrenal mass | 1 0.01 2.65 Adrenocorticotropic hormone deficiency | 1 0.01 2.66 Adrenogenital syndrome | 1 0.01 2.67 Adverse drug reaction | 8 0.08 2.75 Adverse event | 14 0.14 2.89 Affect lability | 1 0.01 2.90 Affective disorder | 1 0.01 2.91 Age-related macular degeneration | 1 0.01 2.92 Ageusia | 1 0.01 2.93 Aggression | 11 0.11 3.04 Agitation | 8 0.08 3.12 Agoraphobia | 1 0.01 3.13 Alanine aminotransferase abnormal | 1 0.01 3.14 Alanine aminotransferase decreased | 1 0.01 3.15 Alanine aminotransferase increased | 14 0.14 3.29 Albuminuria | 1 0.01 3.30 Alcohol abuse | 2 0.02 3.32 Alcohol detoxification | 1 0.01 3.33 Allergic oedema | 1 0.01 3.34 Allergy to animal | 2 0.02 3.36 Allergy to metals | 2 0.02 3.38 Alopecia | 32 0.32 3.70 Altered state of consciousness | 3 0.03 3.73 Amenorrhoea | 3 0.03 3.76 Amnesia | 15 0.15 3.91 Amniotic cavity infection | 1 0.01 3.92 Amylase increased | 2 0.02 3.94 Anaemia | 49 0.49 4.43 Anaemia of chronic disease | 2 0.02 4.45 Anaemia postoperative | 6 0.06 4.51 Anal incontinence | 4 0.04 4.55 Anal prolapse | 1 0.01 4.56 Anal sphincter atony | 1 0.01 4.57 Anal squamous cell carcinoma | 1 0.01 4.58 Anal ulcer | 1 0.01 4.59 Anaphylactic reaction | 6 0.06 4.65 Anaphylactic shock | 5 0.05 4.70 Anastomotic ulcer | 1 0.01 4.71 Aneurysm ruptured | 1 0.01 4.72 Anger | 5 0.05 4.77 Angina pectoris | 10 0.10 4.87 Angina unstable | 2 0.02 4.89 Angiocentric lymphoma | 1 0.01 4.90 Angioedema | 2 0.02 4.92 Angiopathy | 4 0.04 4.96 Anhedonia | 1 0.01 4.97 Ankle fracture | 5 0.05 5.02 Ankylosing spondylitis | 1 0.01 5.03 Anorexia nervosa | 1 0.01 5.04 Anorgasmia | 1 0.01 5.05 Anosmia | 1 0.01 5.06 Anti-Muellerian hormone level decreased | 1 0.01 5.07 Anti-erythropoietin antibody positive | 1 0.01 5.08 Antibody test positive | 1 0.01 5.09 Anticonvulsant drug level above thera.. | 1 0.01 5.10 Antiphospholipid antibodies positive | 1 0.01 5.11 Antiphospholipid syndrome | 1 0.01 5.12 Anuria | 1 0.01 5.13 Anxiety | 49 0.49 5.62 Anxiety disorder | 1 0.01 5.63 Aorta coarctation repair | 1 0.01 5.64 Aortic aneurysm | 2 0.02 5.66 Aortic arteriosclerosis | 3 0.03 5.69 Aortic dilatation | 1 0.01 5.70 Aortic stenosis | 4 0.04 5.74 Aortic valve incompetence | 3 0.03 5.77 Aortic valve stenosis | 1 0.01 5.78 Apathy | 1 0.01 5.79 Apgar score low | 2 0.02 5.81 Aphasia | 4 0.04 5.85 Aphonia | 3 0.03 5.88 Aphthous ulcer | 2 0.02 5.90 Aplasia pure red cell | 1 0.01 5.91 Apnoea | 1 0.01 5.92 Apparent death | 1 0.01 5.93 Appendicectomy | 1 0.01 5.94 Appendicitis | 3 0.03 5.97 Appendicitis perforated | 1 0.01 5.98 Appetite disorder | 1 0.01 5.99 Application site erosion | 1 0.01 6.00 Application site pain | 1 0.01 6.01 Apraxia | 1 0.01 6.02 Areflexia | 2 0.02 6.04 Arrhythmia | 6 0.06 6.10 Arrhythmia supraventricular | 1 0.01 6.11 Arterial disorder | 1 0.01 6.12 Arterial haemorrhage | 1 0.01 6.13 Arterial rupture | 1 0.01 6.14 Arterial thrombosis | 1 0.01 6.15 Arteriosclerosis | 1 0.01 6.16 Arteriospasm coronary | 3 0.03 6.19 Arthralgia | 78 0.78 6.97 Arthritis | 21 0.21 7.18 Arthritis bacterial | 1 0.01 7.19 Arthritis infective | 1 0.01 7.20 Arthrodesis | 1 0.01 7.21 Arthropathy | 16 0.16 7.37 Arthropod bite | 1 0.01 7.38 Arthroscopy | 2 0.02 7.40 Ascites | 6 0.06 7.46 Aspartate aminotransferase abnormal | 1 0.01 7.47 Aspartate aminotransferase increased | 16 0.16 7.63 Aspergillus infection | 2 0.02 7.65 Aspiration | 2 0.02 7.67 Asthenia | 74 0.74 8.41 Asthenopia | 1 0.01 8.42 Asthma | 36 0.36 8.78 Asthma-chronic obstructive pulmonary .. | 1 0.01 8.79 Asthmatic crisis | 1 0.01 8.80 Ataxia | 2 0.02 8.82 Atelectasis | 2 0.02 8.84 Atopy | 1 0.01 8.85 Atrial fibrillation | 22 0.22 9.07 Atrial flutter | 3 0.03 9.10 Atrial septal defect | 2 0.02 9.12 Atrial tachycardia | 1 0.01 9.13 Atrioventricular block first degree | 1 0.01 9.14 Atrioventricular block second degree | 1 0.01 9.15 Atrophic vulvovaginitis | 1 0.01 9.16 Atrophy | 1 0.01 9.17 Attention deficit/hyperactivity disor.. | 5 0.05 9.22 Atypical femur fracture | 4 0.04 9.26 Atypical pneumonia | 2 0.02 9.28 Autism spectrum disorder | 1 0.01 9.29 Autoimmune colitis | 2 0.02 9.31 Autoimmune disorder | 2 0.02 9.33 Autoimmune thyroiditis | 3 0.03 9.36 Automatic bladder | 1 0.01 9.37 Avulsion fracture | 3 0.03 9.40 Back disorder | 3 0.03 9.43 Back injury | 4 0.04 9.47 Back pain | 44 0.44 9.91 Bacteraemia | 1 0.01 9.92 Bacterial allergy | 1 0.01 9.93 Bacterial disease carrier | 1 0.01 9.94 Bacterial infection | 3 0.03 9.97 Bacterial sepsis | 1 0.01 9.98 Balance disorder | 26 0.26 10.24 Balanitis candida | 1 0.01 10.25 Ballismus | 1 0.01 10.26 Barrett's oesophagus | 1 0.01 10.27 Basal cell carcinoma | 11 0.11 10.38 Basal ganglia haemorrhage | 1 0.01 10.39 Basedow's disease | 1 0.01 10.40 Bedridden | 2 0.02 10.42 Benign breast neoplasm | 1 0.01 10.43 Benign congenital hypotonia | 1 0.01 10.44 Benign neoplasm of skin | 1 0.01 10.45 Benign neoplasm of thyroid gland | 1 0.01 10.46 Benign prostatic hyperplasia | 2 0.02 10.48 Bile duct cancer | 1 0.01 10.49 Bile duct stenosis | 2 0.02 10.51 Bile duct stone | 1 0.01 10.52 Biliary cirrhosis | 1 0.01 10.53 Biliary tract disorder | 1 0.01 10.54 Bipolar II disorder | 1 0.01 10.55 Bipolar disorder | 4 0.04 10.59 Bite | 1 0.01 10.60 Bladder cancer | 1 0.01 10.61 Bladder disorder | 1 0.01 10.62 Bladder neoplasm | 2 0.02 10.64 Bladder operation | 1 0.01 10.65 Bladder outlet obstruction | 1 0.01 10.66 Bladder prolapse | 1 0.01 10.67 Bladder transitional cell carcinoma | 1 0.01 10.68 Blast crisis in myelogenous leukaemia | 1 0.01 10.69 Bleeding time prolonged | 1 0.01 10.70 Blindness | 14 0.14 10.84 Blindness cortical | 1 0.01 10.85 Blindness transient | 4 0.04 10.89 Blindness traumatic | 2 0.02 10.91 Blindness unilateral | 6 0.06 10.97 Blister | 6 0.06 11.03 Blister rupture | 1 0.01 11.04 Blood albumin decreased | 1 0.01 11.05 Blood alkaline phosphatase decreased | 2 0.02 11.07 Blood alkaline phosphatase increased | 6 0.06 11.13 Blood bilirubin decreased | 1 0.01 11.14 Blood bilirubin increased | 2 0.02 11.16 Blood blister | 1 0.01 11.17 Blood calcium decreased | 1 0.01 11.18 Blood calcium increased | 1 0.01 11.19 Blood chloride increased | 2 0.02 11.21 Blood cholesterol abnormal | 1 0.01 11.22 Blood cholesterol decreased | 1 0.01 11.23 Blood cholesterol increased | 21 0.21 11.44 Blood count abnormal | 1 0.01 11.45 Blood creatine phosphokinase increased | 5 0.05 11.50 Blood creatinine decreased | 1 0.01 11.51 Blood creatinine increased | 9 0.09 11.60 Blood disorder | 1 0.01 11.61 Blood electrolytes decreased | 1 0.01 11.62 Blood folate increased | 1 0.01 11.63 Blood glucose abnormal | 5 0.05 11.68 Blood glucose decreased | 9 0.09 11.77 Blood glucose increased | 24 0.24 12.01 Blood growth hormone abnormal | 1 0.01 12.02 Blood growth hormone increased | 1 0.01 12.03 Blood immunoglobulin E increased | 2 0.02 12.05 Blood immunoglobulin M increased | 1 0.01 12.06 Blood insulin increased | 2 0.02 12.08 Blood iron decreased | 2 0.02 12.10 Blood lactate dehydrogenase increased | 5 0.05 12.15 Blood lactic acid increased | 1 0.01 12.16 Blood magnesium decreased | 5 0.05 12.21 Blood phosphorus increased | 1 0.01 12.22 Blood potassium decreased | 7 0.07 12.29 Blood potassium increased | 2 0.02 12.31 Blood pressure abnormal | 1 0.01 12.32 Blood pressure decreased | 8 0.08 12.40 Blood pressure diastolic decreased | 1 0.01 12.41 Blood pressure diastolic increased | 1 0.01 12.42 Blood pressure fluctuation | 5 0.05 12.47 Blood pressure increased | 41 0.41 12.88 Blood pressure systolic decreased | 1 0.01 12.89 Blood pressure systolic increased | 9 0.09 12.98 Blood prolactin increased | 2 0.02 13.00 Blood sodium decreased | 4 0.04 13.04 Blood sodium increased | 1 0.01 13.05 Blood test | 1 0.01 13.06 Blood testosterone free increased | 1 0.01 13.07 Blood thyroid stimulating hormone dec.. | 6 0.06 13.13 Blood thyroid stimulating hormone inc.. | 3 0.03 13.16 Blood triglycerides increased | 8 0.08 13.24 Blood urea decreased | 1 0.01 13.25 Blood urea increased | 3 0.03 13.28 Blood uric acid | 1 0.01 13.29 Blood uric acid abnormal | 1 0.01 13.30 Blood uric acid decreased | 1 0.01 13.31 Blood urine present | 3 0.03 13.34 Body height decreased | 8 0.08 13.42 Body height increased | 1 0.01 13.43 Body mass index increased | 2 0.02 13.45 Body temperature decreased | 4 0.04 13.49 Body temperature increased | 3 0.03 13.52 Bone cancer | 1 0.01 13.53 Bone density decreased | 2 0.02 13.55 Bone density increased | 1 0.01 13.56 Bone development abnormal | 1 0.01 13.57 Bone disorder | 10 0.10 13.67 Bone erosion | 1 0.01 13.68 Bone lesion | 2 0.02 13.70 Bone loss | 1 0.01 13.71 Bone marrow disorder | 1 0.01 13.72 Bone marrow failure | 4 0.04 13.76 Bone metabolism disorder | 1 0.01 13.77 Bone operation | 1 0.01 13.78 Bone pain | 15 0.15 13.93 Bone sarcoma | 1 0.01 13.94 Borderline glaucoma | 1 0.01 13.95 Brachiocephalic vein thrombosis | 1 0.01 13.96 Bradycardia | 8 0.08 14.04 Bradyphrenia | 2 0.02 14.06 Brain abscess | 1 0.01 14.07 Brain death | 1 0.01 14.08 Brain herniation | 1 0.01 14.09 Brain injury | 3 0.03 14.12 Brain natriuretic peptide increased | 1 0.01 14.13 Brain neoplasm | 1 0.01 14.14 Brain oedema | 3 0.03 14.17 Brain scan abnormal | 1 0.01 14.18 Brain tumour operation | 1 0.01 14.19 Breast calcifications | 1 0.01 14.20 Breast cancer | 11 0.11 14.31 Breast cancer female | 2 0.02 14.33 Breast cancer metastatic | 1 0.01 14.34 Breast cancer recurrent | 2 0.02 14.36 Breast cyst | 1 0.01 14.37 Breast disorder | 2 0.02 14.39 Breast enlargement | 1 0.01 14.40 Breast haemorrhage | 1 0.01 14.41 Breast malformation | 1 0.01 14.42 Breast mass | 3 0.03 14.45 Breast operation | 1 0.01 14.46 Breast pain | 2 0.02 14.48 Breast swelling | 1 0.01 14.49 Breast tenderness | 2 0.02 14.51 Breath odour | 1 0.01 14.52 Bronchial disorder | 1 0.01 14.53 Bronchiectasis | 2 0.02 14.55 Bronchitis | 23 0.23 14.78 Bronchitis chronic | 1 0.01 14.79 Bronchoalveolar lavage abnormal | 1 0.01 14.80 Bronchospasm | 2 0.02 14.82 Brunner's gland hyperplasia | 1 0.01 14.83 Bruxism | 1 0.01 14.84 Bulimia nervosa | 1 0.01 14.85 Burning sensation | 10 0.10 14.95 Bursitis | 9 0.09 15.04 C-reactive protein increased | 12 0.12 15.16 Cachexia | 1 0.01 15.17 Calcification of muscle | 1 0.01 15.18 Calculus bladder | 1 0.01 15.19 Calculus urinary | 1 0.01 15.20 Campylobacter colitis | 1 0.01 15.21 Cancer in remission | 1 0.01 15.22 Candida infection | 4 0.04 15.26 Cardiac arrest | 10 0.10 15.36 Cardiac assistance device user | 1 0.01 15.37 Cardiac discomfort | 1 0.01 15.38 Cardiac disorder | 18 0.18 15.56 Cardiac dysfunction | 1 0.01 15.57 Cardiac failure | 9 0.09 15.66 Cardiac failure acute | 1 0.01 15.67 Cardiac failure congestive | 14 0.14 15.81 Cardiac flutter | 3 0.03 15.84 Cardiac murmur | 7 0.07 15.91 Cardiac tamponade | 2 0.02 15.93 Cardiac valve disease | 4 0.04 15.97 Cardiac valve rupture | 1 0.01 15.98 Cardio-respiratory arrest | 9 0.09 16.07 Cardiogenic shock | 2 0.02 16.09 Cardiomegaly | 5 0.05 16.14 Cardiomyopathy | 2 0.02 16.16 Cardiopulmonary failure | 1 0.01 16.17 Cardiovascular disorder | 5 0.05 16.22 Cardioversion | 1 0.01 16.23 Carotid arteriosclerosis | 1 0.01 16.24 Carotid artery occlusion | 1 0.01 16.25 Carotid artery stenosis | 1 0.01 16.26 Carpal tunnel decompression | 1 0.01 16.27 Carpal tunnel syndrome | 5 0.05 16.32 Cartilage atrophy | 1 0.01 16.33 Cartilage injury | 1 0.01 16.34 Castleman's disease | 1 0.01 16.35 Cataract | 18 0.18 16.53 Cataract operation | 4 0.04 16.57 Cataract subcapsular | 1 0.01 16.58 Catatonia | 1 0.01 16.59 Catheter site haemorrhage | 1 0.01 16.60 Catheter site rash | 1 0.01 16.61 Cellulitis | 9 0.09 16.70 Central nervous system fungal infection | 1 0.01 16.71 Central nervous system lesion | 3 0.03 16.74 Cerebellar infarction | 1 0.01 16.75 Cerebral artery occlusion | 1 0.01 16.76 Cerebral disorder | 2 0.02 16.78 Cerebral haemorrhage | 5 0.05 16.83 Cerebral infarction | 5 0.05 16.88 Cerebral ischaemia | 1 0.01 16.89 Cerebral small vessel ischaemic disease | 1 0.01 16.90 Cerebral vasoconstriction | 1 0.01 16.91 Cerebrovascular accident | 27 0.27 17.18 Cerebrovascular disorder | 1 0.01 17.19 Cervical dysplasia | 1 0.01 17.20 Cervical vertebral fracture | 1 0.01 17.21 Cervix disorder | 1 0.01 17.22 Chemical burns of eye | 1 0.01 17.23 Chemotherapy | 1 0.01 17.24 Chest discomfort | 13 0.13 17.37 Chest injury | 1 0.01 17.38 Chest pain | 24 0.24 17.62 Chills | 12 0.12 17.74 Choking | 2 0.02 17.76 Cholangiocarcinoma | 1 0.01 17.77 Cholangitis | 3 0.03 17.80 Cholecystectomy | 4 0.04 17.84 Cholecystitis | 3 0.03 17.87 Cholecystitis acute | 2 0.02 17.89 Cholecystitis chronic | 1 0.01 17.90 Cholecystitis infective | 1 0.01 17.91 Cholelithiasis | 9 0.09 18.00 Cholestasis | 2 0.02 18.02 Cholinergic syndrome | 1 0.01 18.03 Chondritis | 1 0.01 18.04 Chondrocalcinosis | 1 0.01 18.05 Chondrocalcinosis pyrophosphate | 1 0.01 18.06 Chondropathy | 2 0.02 18.08 Chorioretinal scar | 1 0.01 18.09 Chorioretinitis | 1 0.01 18.10 Chromaturia | 1 0.01 18.11 Chromoblastomycosis | 1 0.01 18.12 Chronic fatigue syndrome | 1 0.01 18.13 Chronic graft versus host disease | 1 0.01 18.14 Chronic idiopathic pain syndrome | 1 0.01 18.15 Chronic kidney disease | 9 0.09 18.24 Chronic lymphocytic leukaemia | 4 0.04 18.28 Chronic myeloid leukaemia | 2 0.02 18.30 Chronic myeloid leukaemia transformat.. | 1 0.01 18.31 Chronic obstructive pulmonary disease | 12 0.12 18.43 Chronic respiratory failure | 1 0.01 18.44 Chronic sinusitis | 1 0.01 18.45 Chronic spontaneous urticaria | 1 0.01 18.46 Circadian rhythm sleep disorder | 1 0.01 18.47 Circulatory collapse | 4 0.04 18.51 Circumstance or information capable o.. | 3 0.03 18.54 Cleft lip and palate | 3 0.03 18.57 Cleft palate repair | 1 0.01 18.58 Clostridium difficile infection | 3 0.03 18.61 Clumsiness | 1 0.01 18.62 Cluster headache | 1 0.01 18.63 Coagulation factor VIII level decreased | 1 0.01 18.64 Coagulopathy | 1 0.01 18.65 Coccidioidomycosis | 2 0.02 18.67 Coeliac disease | 2 0.02 18.69 Cognitive disorder | 17 0.17 18.86 Cold sweat | 4 0.04 18.90 Colitis | 4 0.04 18.94 Colitis ischaemic | 1 0.01 18.95 Colitis ulcerative | 3 0.03 18.98 Colon cancer | 4 0.04 19.02 Colonic abscess | 1 0.01 19.03 Colorectal adenocarcinoma | 1 0.01 19.04 Colorectal cancer | 1 0.01 19.05 Coma | 11 0.11 19.16 Coma hepatic | 1 0.01 19.17 Coma scale abnormal | 2 0.02 19.19 Compartment syndrome | 2 0.02 19.21 Complement factor increased | 1 0.01 19.22 Completed suicide | 10 0.10 19.32 Complication associated with device | 2 0.02 19.34 Complication of device insertion | 2 0.02 19.36 Complication of device removal | 1 0.01 19.37 Complications of transplanted kidney | 1 0.01 19.38 Compression fracture | 3 0.03 19.41 Concomitant disease progression | 1 0.01 19.42 Concussion | 5 0.05 19.47 Condition aggravated | 39 0.39 19.86 Conductive deafness | 1 0.01 19.87 Confusional state | 20 0.20 20.07 Congenital genital malformation female | 1 0.01 20.08 Congenital musculoskeletal anomaly | 1 0.01 20.09 Conjunctival discolouration | 1 0.01 20.10 Conjunctivitis | 2 0.02 20.12 Connective tissue disorder | 2 0.02 20.14 Constipation | 34 0.34 20.48 Contraindicated product administered | 1 0.01 20.49 Contusion | 22 0.22 20.71 Convulsions local | 1 0.01 20.72 Coordination abnormal | 3 0.03 20.75 Cor pulmonale | 1 0.01 20.76 Corneal abrasion | 1 0.01 20.77 Corneal deposits | 3 0.03 20.80 Corneal disorder | 1 0.01 20.81 Corneal infection | 1 0.01 20.82 Corneal lesion | 1 0.01 20.83 Corneal oedema | 2 0.02 20.85 Corneal perforation | 1 0.01 20.86 Coronary artery disease | 9 0.09 20.95 Coronary artery occlusion | 6 0.06 21.01 Coronary artery stenosis | 1 0.01 21.02 Cortisol decreased | 3 0.03 21.05 Cortisol increased | 1 0.01 21.06 Cough | 37 0.37 21.43 Cranial nerve disorder | 1 0.01 21.44 Craniocerebral injury | 1 0.01 21.45 Crepitations | 1 0.01 21.46 Crohn's disease | 7 0.07 21.53 Crying | 8 0.08 21.61 Cyanosis | 2 0.02 21.63 Cyst | 3 0.03 21.66 Cystic fibrosis | 1 0.01 21.67 Cystitis | 7 0.07 21.74 Cystitis noninfective | 1 0.01 21.75 Cystoscopy | 1 0.01 21.76 Cytokine release syndrome | 2 0.02 21.78 Cytomegalovirus infection | 2 0.02 21.80 Cytomegalovirus test positive | 1 0.01 21.81 Cytomegalovirus viraemia | 1 0.01 21.82 Cytopenia | 1 0.01 21.83 Dacryostenosis acquired | 1 0.01 21.84 Dandruff | 1 0.01 21.85 Deafness | 9 0.09 21.94 Deafness bilateral | 2 0.02 21.96 Deafness neurosensory | 2 0.02 21.98 Deafness unilateral | 1 0.01 21.99 Death | 31 0.31 22.30 Death neonatal | 2 0.02 22.32 Decreased activity | 1 0.01 22.33 Decreased appetite | 35 0.35 22.68 Decreased interest | 1 0.01 22.69 Decubitus ulcer | 3 0.03 22.72 Deep vein thrombosis | 11 0.11 22.83 Defaecation urgency | 3 0.03 22.86 Deformity | 2 0.02 22.88 Deformity of orbit | 1 0.01 22.89 Dehydration | 16 0.16 23.05 Delayed puberty | 1 0.01 23.06 Delirium | 4 0.04 23.10 Delusion | 5 0.05 23.15 Dementia | 3 0.03 23.18 Dementia Alzheimer's type | 1 0.01 23.19 Demyelination | 2 0.02 23.21 Dengue fever | 3 0.03 23.24 Dental implantation | 1 0.01 23.25 Dental operation | 1 0.01 23.26 Dependence | 1 0.01 23.27 Dependent personality disorder | 1 0.01 23.28 Depressed level of consciousness | 5 0.05 23.33 Depressed mood | 7 0.07 23.40 Depression | 51 0.51 23.91 Depression suicidal | 1 0.01 23.92 Depressive symptom | 1 0.01 23.93 Dermal cyst | 1 0.01 23.94 Dermatillomania | 1 0.01 23.95 Dermatitis | 3 0.03 23.98 Dermatitis acneiform | 2 0.02 24.00 Dermatitis allergic | 3 0.03 24.03 Dermatitis bullous | 1 0.01 24.04 Dermatitis contact | 1 0.01 24.05 Dermatitis diaper | 1 0.01 24.06 Dermatitis herpetiformis | 1 0.01 24.07 Dermatophytosis of nail | 1 0.01 24.08 Developmental delay | 3 0.03 24.11 Developmental hip dysplasia | 2 0.02 24.13 Device breakage | 1 0.01 24.14 Device damage | 1 0.01 24.15 Device defective | 1 0.01 24.16 Device difficult to use | 2 0.02 24.18 Device dislocation | 6 0.06 24.24 Device embolisation | 1 0.01 24.25 Device failure | 8 0.08 24.33 Device interaction | 1 0.01 24.34 Device issue | 8 0.08 24.42 Device loosening | 3 0.03 24.45 Device malfunction | 5 0.05 24.50 Device related infection | 3 0.03 24.53 Diabetes insipidus | 1 0.01 24.54 Diabetes mellitus | 22 0.22 24.76 Diabetes mellitus inadequate control | 1 0.01 24.77 Diabetic dyslipidaemia | 1 0.01 24.78 Diabetic neuropathy | 1 0.01 24.79 Diarrhoea | 91 0.91 25.70 Diarrhoea haemorrhagic | 1 0.01 25.71 Dieulafoy's vascular malformation | 1 0.01 25.72 Diffuse large B-cell lymphoma | 1 0.01 25.73 Diffuse large B-cell lymphoma stage I | 1 0.01 25.74 Diplopia | 3 0.03 25.77 Disability | 1 0.01 25.78 Discomfort | 9 0.09 25.87 Disease progression | 7 0.07 25.94 Disease recurrence | 3 0.03 25.97 Disorientation | 4 0.04 26.01 Disruptive mood dysregulation disorder | 1 0.01 26.02 Disseminated intravascular coagulation | 6 0.06 26.08 Disturbance in attention | 10 0.10 26.18 Disturbance in social behaviour | 3 0.03 26.21 Diverticulitis | 4 0.04 26.25 Diverticulum | 4 0.04 26.29 Diverticulum intestinal | 1 0.01 26.30 Dizziness | 59 0.59 26.89 Drooling | 1 0.01 26.90 Drowning | 1 0.01 26.91 Drug abuse | 4 0.04 26.95 Drug administered to patient of inapp.. | 2 0.02 26.97 Drug administration error | 6 0.06 27.03 Drug clearance decreased | 1 0.01 27.04 Drug dependence | 5 0.05 27.09 Drug dispensing error | 1 0.01 27.10 Drug dose omission | 55 0.55 27.65 Drug effect decreased | 4 0.04 27.69 Drug effect incomplete | 7 0.07 27.76 Drug eruption | 1 0.01 27.77 Drug hypersensitivity | 108 1.08 28.85 Drug ineffective | 102 1.02 29.87 Drug ineffective for unapproved indic.. | 4 0.04 29.91 Drug interaction | 16 0.16 30.07 Drug intolerance | 12 0.12 30.19 Drug prescribing error | 5 0.05 30.24 Drug reaction with eosinophilia and s.. | 3 0.03 30.27 Drug resistance | 2 0.02 30.29 Drug screen positive | 1 0.01 30.30 Drug withdrawal syndrome | 1 0.01 30.31 Drug withdrawal syndrome neonatal | 1 0.01 30.32 Drug-induced liver injury | 3 0.03 30.35 Dry age-related macular degeneration | 1 0.01 30.36 Dry eye | 7 0.07 30.43 Dry mouth | 9 0.09 30.52 Dry skin | 7 0.07 30.59 Dry throat | 1 0.01 30.60 Dumping syndrome | 1 0.01 30.61 Duodenal ulcer | 2 0.02 30.63 Dupuytren's contracture | 1 0.01 30.64 Dust allergy | 1 0.01 30.65 Dysaesthesia | 1 0.01 30.66 Dysarthria | 5 0.05 30.71 Dyscalculia | 1 0.01 30.72 Dysgeusia | 5 0.05 30.77 Dysgraphia | 3 0.03 30.80 Dyskinesia | 4 0.04 30.84 Dyslexia | 1 0.01 30.85 Dyslipidaemia | 2 0.02 30.87 Dysmenorrhoea | 1 0.01 30.88 Dysmetria | 1 0.01 30.89 Dysmorphism | 1 0.01 30.90 Dyspareunia | 2 0.02 30.92 Dyspepsia | 17 0.17 31.09 Dysphagia | 20 0.20 31.29 Dysphemia | 3 0.03 31.32 Dysphonia | 14 0.14 31.46 Dyspnoea | 91 0.91 32.37 Dyspnoea exertional | 6 0.06 32.43 Dyspraxia | 1 0.01 32.44 Dysstasia | 5 0.05 32.49 Dystonia | 2 0.02 32.51 Dysuria | 6 0.06 32.57 Ear disorder | 2 0.02 32.59 Ear infection | 8 0.08 32.67 Ear pain | 3 0.03 32.70 Ear swelling | 1 0.01 32.71 Ear tube insertion | 1 0.01 32.72 Ear, nose and throat examination abno.. | 1 0.01 32.73 Eating disorder | 11 0.11 32.84 Ecchymosis | 2 0.02 32.86 Echopraxia | 1 0.01 32.87 Ectopic pregnancy | 2 0.02 32.89 Ectopic pregnancy with contraceptive .. | 1 0.01 32.90 Eczema | 5 0.05 32.95 Effusion | 1 0.01 32.96 Ejaculation disorder | 2 0.02 32.98 Ejaculation failure | 3 0.03 33.01 Ejection fraction decreased | 1 0.01 33.02 Elbow deformity | 1 0.01 33.03 Elbow operation | 1 0.01 33.04 Electrocardiogram PR prolongation | 1 0.01 33.05 Electrocardiogram QT prolonged | 1 0.01 33.06 Electrocardiogram abnormal | 2 0.02 33.08 Electrocardiogram low voltage | 1 0.01 33.09 Electrolyte imbalance | 4 0.04 33.13 Embedded device | 1 0.01 33.14 Embolism | 2 0.02 33.16 Embolism venous | 1 0.01 33.17 Emotional disorder | 9 0.09 33.26 Emotional distress | 11 0.11 33.37 Emphysema | 3 0.03 33.40 Enanthema | 2 0.02 33.42 Encephalitis | 2 0.02 33.44 Encephalopathy | 4 0.04 33.48 Encopresis | 2 0.02 33.50 End stage renal disease | 2 0.02 33.52 Endocrine disorder | 2 0.02 33.54 Endodontic procedure | 1 0.01 33.55 Endotracheal intubation | 2 0.02 33.57 Energy increased | 1 0.01 33.58 Engraftment syndrome | 1 0.01 33.59 Enostosis | 1 0.01 33.60 Enteritis | 1 0.01 33.61 Enteritis infectious | 1 0.01 33.62 Enteritis leukopenic | 1 0.01 33.63 Enterobacter sepsis | 1 0.01 33.64 Enterococcal sepsis | 1 0.01 33.65 Enterocolitis | 1 0.01 33.66 Enterostomy | 1 0.01 33.67 Enuresis | 1 0.01 33.68 Eosinophil count increased | 5 0.05 33.73 Eosinophil percentage increased | 1 0.01 33.74 Epicondylitis | 2 0.02 33.76 Epidermal necrosis | 1 0.01 33.77 Epilepsy | 5 0.05 33.82 Epiphyses delayed fusion | 2 0.02 33.84 Epistaxis | 17 0.17 34.01 Epstein-Barr virus associated lymphop.. | 1 0.01 34.02 Epstein-Barr virus infection | 1 0.01 34.03 Erectile dysfunction | 4 0.04 34.07 Erosive duodenitis | 1 0.01 34.08 Erysipelas | 2 0.02 34.10 Erythema | 16 0.16 34.26 Erythema nodosum | 1 0.01 34.27 Escherichia bacteraemia | 2 0.02 34.29 Escherichia infection | 1 0.01 34.30 Escherichia sepsis | 1 0.01 34.31 Escherichia test positive | 1 0.01 34.32 Escherichia urinary tract infection | 1 0.01 34.33 Essential hypertension | 2 0.02 34.35 Eustachian tube disorder | 1 0.01 34.36 Eustachian tube dysfunction | 1 0.01 34.37 Excessive eye blinking | 1 0.01 34.38 Exercise tolerance decreased | 1 0.01 34.39 Exophthalmos | 2 0.02 34.41 Exostosis | 4 0.04 34.45 Expanded disability status scale scor.. | 2 0.02 34.47 Expired product administered | 4 0.04 34.51 Exposed bone in jaw | 3 0.03 34.54 Exposure during pregnancy | 13 0.13 34.67 Exposure to communicable disease | 1 0.01 34.68 Exposure via breast milk | 5 0.05 34.73 Extra dose administered | 2 0.02 34.75 Extrapyramidal disorder | 1 0.01 34.76 Extrasystoles | 2 0.02 34.78 Eye complication associated with device | 1 0.01 34.79 Eye contusion | 1 0.01 34.80 Eye disorder | 5 0.05 34.85 Eye haemorrhage | 2 0.02 34.87 Eye infection | 1 0.01 34.88 Eye injury | 2 0.02 34.90 Eye irritation | 6 0.06 34.96 Eye movement disorder | 2 0.02 34.98 Eye operation | 1 0.01 34.99 Eye pain | 11 0.11 35.10 Eye paraesthesia | 1 0.01 35.11 Eye pruritus | 4 0.04 35.15 Eye swelling | 6 0.06 35.21 Eyelid ptosis | 3 0.03 35.24 Face injury | 4 0.04 35.28 Face oedema | 1 0.01 35.29 Facial operation | 1 0.01 35.30 Facial pain | 3 0.03 35.33 Facial paralysis | 3 0.03 35.36 Facial paresis | 1 0.01 35.37 Faecaloma | 1 0.01 35.38 Faeces discoloured | 2 0.02 35.40 Faeces hard | 1 0.01 35.41 Failure to thrive | 1 0.01 35.42 Fall | 89 0.89 36.31 Fat tissue increased | 1 0.01 36.32 Fatigue | 103 1.03 37.35 Fatty acid deficiency | 1 0.01 37.36 Fear | 4 0.04 37.40 Fear of closed spaces | 1 0.01 37.41 Fear of disease | 1 0.01 37.42 Febrile bone marrow aplasia | 2 0.02 37.44 Febrile neutropenia | 19 0.19 37.63 Feeding disorder | 5 0.05 37.68 Feeling abnormal | 26 0.26 37.94 Feeling cold | 6 0.06 38.00 Feeling drunk | 1 0.01 38.01 Feeling hot | 2 0.02 38.03 Feeling of body temperature change | 1 0.01 38.04 Female genital tract fistula | 1 0.01 38.05 Femoral artery dissection | 1 0.01 38.06 Femoral bruit | 1 0.01 38.07 Femoral neck fracture | 3 0.03 38.10 Femur fracture | 55 0.55 38.65 Fibrin D dimer increased | 1 0.01 38.66 Fibrin degradation products increased | 1 0.01 38.67 Fibrin increased | 1 0.01 38.68 Fibromyalgia | 11 0.11 38.79 Fibrosis | 1 0.01 38.80 Fibula fracture | 2 0.02 38.82 Finger deformity | 1 0.01 38.83 Fistula | 2 0.02 38.85 Flat affect | 1 0.01 38.86 Flat anterior chamber of eye | 1 0.01 38.87 Flatulence | 6 0.06 38.93 Fluid retention | 12 0.12 39.05 Flushing | 8 0.08 39.13 Foaming at mouth | 1 0.01 39.14 Focal segmental glomerulosclerosis | 1 0.01 39.15 Foetal death | 3 0.03 39.18 Foetal disorder | 1 0.01 39.19 Foetal exposure during pregnancy | 18 0.18 39.37 Foetal growth restriction | 5 0.05 39.42 Foetal malformation | 1 0.01 39.43 Foetal malnutrition | 2 0.02 39.45 Folate deficiency | 1 0.01 39.46 Folliculitis | 1 0.01 39.47 Food allergy | 6 0.06 39.53 Food craving | 3 0.03 39.56 Food poisoning | 1 0.01 39.57 Foot deformity | 7 0.07 39.64 Foot fracture | 8 0.08 39.72 Foot operation | 1 0.01 39.73 Forced expiratory volume decreased | 6 0.06 39.79 Forced vital capacity decreased | 1 0.01 39.80 Foreign body in reproductive tract | 1 0.01 39.81 Foreign body in respiratory tract | 1 0.01 39.82 Foreign body sensation in eyes | 1 0.01 39.83 Fracture | 7 0.07 39.90 Fracture delayed union | 1 0.01 39.91 Fracture nonunion | 6 0.06 39.97 Frequent bowel movements | 1 0.01 39.98 Full blood count decreased | 2 0.02 40.00 Functional gastrointestinal disorder | 3 0.03 40.03 Fungal infection | 3 0.03 40.06 Fungal rhinitis | 1 0.01 40.07 Fungal skin infection | 2 0.02 40.09 Fungal test positive | 1 0.01 40.10 Gait disturbance | 63 0.63 40.73 Gait inability | 10 0.10 40.83 Galactorrhoea | 1 0.01 40.84 Gallbladder disorder | 4 0.04 40.88 Gallbladder empyema | 1 0.01 40.89 Gallbladder operation | 2 0.02 40.91 Gallbladder perforation | 1 0.01 40.92 Gamma-glutamyltransferase increased | 7 0.07 40.99 Gangrene | 2 0.02 41.01 Gastric cancer | 1 0.01 41.02 Gastric disorder | 6 0.06 41.08 Gastric haemorrhage | 1 0.01 41.09 Gastric neoplasm | 1 0.01 41.10 Gastric ulcer | 4 0.04 41.14 Gastrinoma | 2 0.02 41.16 Gastritis | 6 0.06 41.22 Gastritis haemorrhagic | 1 0.01 41.23 Gastroenteritis | 10 0.10 41.33 Gastroenteritis radiation | 1 0.01 41.34 Gastroenteritis viral | 5 0.05 41.39 Gastrointestinal disorder | 12 0.12 41.51 Gastrointestinal haemorrhage | 17 0.17 41.68 Gastrointestinal infection | 1 0.01 41.69 Gastrointestinal motility disorder | 2 0.02 41.71 Gastrointestinal necrosis | 1 0.01 41.72 Gastrointestinal neoplasm | 1 0.01 41.73 Gastrointestinal oedema | 1 0.01 41.74 Gastrointestinal pain | 1 0.01 41.75 Gastrointestinal stoma necrosis | 1 0.01 41.76 Gastrointestinal stromal tumour | 1 0.01 41.77 Gastrointestinal toxicity | 1 0.01 41.78 Gastrooesophageal reflux disease | 29 0.29 42.07 Gastropleural fistula | 1 0.01 42.08 General physical health deterioration | 28 0.28 42.36 General symptom | 1 0.01 42.37 Generalised anxiety disorder | 1 0.01 42.38 Generalised oedema | 1 0.01 42.39 Generalised tonic-clonic seizure | 5 0.05 42.44 Genital discomfort | 1 0.01 42.45 Genital haemorrhage | 5 0.05 42.50 Genital herpes | 1 0.01 42.51 Genital hypoaesthesia | 1 0.01 42.52 Gestational diabetes | 1 0.01 42.53 Gestational hypertension | 2 0.02 42.55 Gingival bleeding | 3 0.03 42.58 Gingival discomfort | 1 0.01 42.59 Gingival disorder | 1 0.01 42.60 Gingival hypertrophy | 1 0.01 42.61 Gingival pain | 3 0.03 42.64 Glaucoma | 4 0.04 42.68 Globulins decreased | 1 0.01 42.69 Glomerular filtration rate decreased | 1 0.01 42.70 Glomerulonephritis | 3 0.03 42.73 Glossitis | 2 0.02 42.75 Glossodynia | 2 0.02 42.77 Glucose tolerance impaired | 3 0.03 42.80 Glycosylated haemoglobin increased | 8 0.08 42.88 Goitre | 4 0.04 42.92 Gonorrhoea | 1 0.01 42.93 Gout | 1 0.01 42.94 Graft versus host disease | 3 0.03 42.97 Graft versus host disease in gastroin.. | 1 0.01 42.98 Graft versus host disease in liver | 1 0.01 42.99 Graft versus host disease in skin | 1 0.01 43.00 Granulocytes abnormal | 1 0.01 43.01 Granulomatous liver disease | 1 0.01 43.02 Grimacing | 1 0.01 43.03 Grip strength decreased | 2 0.02 43.05 Groin pain | 5 0.05 43.10 Gross motor delay | 1 0.01 43.11 Growth hormone deficiency | 1 0.01 43.12 Growth retardation | 13 0.13 43.25 Guillain-Barre syndrome | 1 0.01 43.26 Gynaecomastia | 4 0.04 43.30 HELLP syndrome | 1 0.01 43.31 Haemangioma | 1 0.01 43.32 Haematemesis | 2 0.02 43.34 Haematochezia | 7 0.07 43.41 Haematocrit abnormal | 1 0.01 43.42 Haematocrit decreased | 3 0.03 43.45 Haematocrit increased | 1 0.01 43.46 Haematoma | 11 0.11 43.57 Haematospermia | 1 0.01 43.58 Haematotoxicity | 2 0.02 43.60 Haematuria | 5 0.05 43.65 Haemodynamic instability | 2 0.02 43.67 Haemoglobin | 1 0.01 43.68 Haemoglobin abnormal | 1 0.01 43.69 Haemoglobin decreased | 17 0.17 43.86 Haemoglobin increased | 2 0.02 43.88 Haemolysis | 4 0.04 43.92 Haemolytic anaemia | 1 0.01 43.93 Haemoptysis | 1 0.01 43.94 Haemorrhage | 14 0.14 44.08 Haemorrhage in pregnancy | 1 0.01 44.09 Haemorrhage intracranial | 1 0.01 44.10 Haemorrhage subcutaneous | 1 0.01 44.11 Haemorrhagic anaemia | 7 0.07 44.18 Haemorrhagic stroke | 4 0.04 44.22 Haemorrhoidal haemorrhage | 1 0.01 44.23 Haemorrhoids | 9 0.09 44.32 Haemothorax | 1 0.01 44.33 Hallucination | 12 0.12 44.45 Hallucination, auditory | 5 0.05 44.50 Hallucination, visual | 1 0.01 44.51 Hand deformity | 4 0.04 44.55 Hand fracture | 4 0.04 44.59 Head and neck cancer stage III | 1 0.01 44.60 Head discomfort | 3 0.03 44.63 Head injury | 7 0.07 44.70 Head titubation | 1 0.01 44.71 Headache | 89 0.89 45.60 Hearing disability | 1 0.01 45.61 Heart disease congenital | 1 0.01 45.62 Heart rate decreased | 5 0.05 45.67 Heart rate increased | 19 0.19 45.86 Heart rate irregular | 3 0.03 45.89 Heart valve incompetence | 1 0.01 45.90 Heart valve operation | 1 0.01 45.91 Heavy exposure to ultraviolet light | 1 0.01 45.92 Helicobacter infection | 1 0.01 45.93 Hemiparesis | 8 0.08 46.01 Hemiplegia | 4 0.04 46.05 Hemiplegic migraine | 1 0.01 46.06 Hepatic cancer | 1 0.01 46.07 Hepatic cancer metastatic | 1 0.01 46.08 Hepatic cirrhosis | 1 0.01 46.09 Hepatic cyst | 1 0.01 46.10 Hepatic encephalopathy | 2 0.02 46.12 Hepatic enzyme decreased | 1 0.01 46.13 Hepatic enzyme increased | 7 0.07 46.20 Hepatic failure | 5 0.05 46.25 Hepatic function abnormal | 2 0.02 46.27 Hepatic lesion | 2 0.02 46.29 Hepatic necrosis | 2 0.02 46.31 Hepatic neoplasm | 1 0.01 46.32 Hepatic pain | 4 0.04 46.36 Hepatic steatosis | 4 0.04 46.40 Hepatitis | 5 0.05 46.45 Hepatitis B | 1 0.01 46.46 Hepatitis B reactivation | 2 0.02 46.48 Hepatitis C | 3 0.03 46.51 Hepatitis acute | 1 0.01 46.52 Hepatitis cholestatic | 1 0.01 46.53 Hepatitis fulminant | 1 0.01 46.54 Hepatobiliary disease | 1 0.01 46.55 Hepatocellular carcinoma | 1 0.01 46.56 Hepatocellular injury | 2 0.02 46.58 Hepatomegaly | 1 0.01 46.59 Hepatorenal failure | 1 0.01 46.60 Hepatosplenic T-cell lymphoma | 1 0.01 46.61 Hernia | 8 0.08 46.69 Hernia repair | 3 0.03 46.72 Herpes simplex | 1 0.01 46.73 Herpes virus infection | 2 0.02 46.75 Herpes zoster | 14 0.14 46.89 Heyde's syndrome | 1 0.01 46.90 Hiatus hernia | 7 0.07 46.97 Hiccups | 4 0.04 47.01 High arched palate | 1 0.01 47.02 High density lipoprotein decreased | 2 0.02 47.04 High density lipoprotein increased | 2 0.02 47.06 Hip arthroplasty | 8 0.08 47.14 Hip fracture | 6 0.06 47.20 Hip surgery | 1 0.01 47.21 Histiocytosis haematophagic | 2 0.02 47.23 Hodgkin's disease | 1 0.01 47.24 Homeless | 1 0.01 47.25 Homicidal ideation | 3 0.03 47.28 Homicide | 1 0.01 47.29 Hospitalisation | 11 0.11 47.40 Hot flush | 12 0.12 47.52 Human herpesvirus 8 infection | 1 0.01 47.53 Humerus fracture | 3 0.03 47.56 Hunger | 2 0.02 47.58 Hydrocephalus | 1 0.01 47.59 Hydronephrosis | 1 0.01 47.60 Hydrothorax | 1 0.01 47.61 Hyperacusis | 1 0.01 47.62 Hyperaesthesia | 1 0.01 47.63 Hyperammonaemic encephalopathy | 1 0.01 47.64 Hyperbilirubinaemia | 1 0.01 47.65 Hypercalcaemia | 3 0.03 47.68 Hyperchlorhydria | 1 0.01 47.69 Hypercholesterolaemia | 5 0.05 47.74 Hypergammaglobulinaemia benign monocl.. | 1 0.01 47.75 Hyperglycaemia | 16 0.16 47.91 Hyperhidrosis | 18 0.18 48.09 Hyperkalaemia | 4 0.04 48.13 Hyperkeratosis | 4 0.04 48.17 Hyperlactacidaemia | 1 0.01 48.18 Hyperleukocytosis | 1 0.01 48.19 Hyperlipasaemia | 1 0.01 48.20 Hyperlipidaemia | 15 0.15 48.35 Hypernatraemia | 2 0.02 48.37 Hyperparathyroidism | 1 0.01 48.38 Hyperparathyroidism secondary | 1 0.01 48.39 Hyperphagia | 1 0.01 48.40 Hyperphosphataemia | 1 0.01 48.41 Hypersensitivity | 28 0.28 48.69 Hypersensitivity vasculitis | 1 0.01 48.70 Hypersomnia | 4 0.04 48.74 Hypertension | 70 0.70 49.44 Hypertensive crisis | 1 0.01 49.45 Hypertensive encephalopathy | 1 0.01 49.46 Hypertensive heart disease | 1 0.01 49.47 Hyperthermia | 2 0.02 49.49 Hyperthyroidism | 2 0.02 49.51 Hypertonia | 3 0.03 49.54 Hypertonic bladder | 1 0.01 49.55 Hypertransaminasaemia | 1 0.01 49.56 Hypertrichosis | 2 0.02 49.58 Hypertriglyceridaemia | 1 0.01 49.59 Hypertrophic anal papilla | 1 0.01 49.60 Hyperuricaemia | 1 0.01 49.61 Hypoacusis | 8 0.08 49.69 Hypoaesthesia | 26 0.26 49.95 Hypoaesthesia oral | 3 0.03 49.98 Hypocalcaemia | 7 0.07 50.05 Hypogammaglobulinaemia | 2 0.02 50.07 Hypoglycaemia | 9 0.09 50.16 Hypoglycaemia unawareness | 1 0.01 50.17 Hypogonadism | 2 0.02 50.19 Hypohidrosis | 1 0.01 50.20 Hypokalaemia | 15 0.15 50.35 Hypokinesia | 4 0.04 50.39 Hypomagnesaemia | 5 0.05 50.44 Hypomania | 1 0.01 50.45 Hyponatraemia | 13 0.13 50.58 Hypoparathyroidism secondary | 2 0.02 50.60 Hypophagia | 2 0.02 50.62 Hypophosphataemia | 3 0.03 50.65 Hypoprothrombinaemia | 1 0.01 50.66 Hypotension | 20 0.20 50.86 Hypothyroidism | 13 0.13 50.99 Hypotonia | 2 0.02 51.01 Hypovolaemia | 2 0.02 51.03 Hypoxia | 7 0.07 51.10 Hypoxic-ischaemic encephalopathy | 1 0.01 51.11 Hysterectomy | 6 0.06 51.17 Hysterosalpingo-oophorectomy | 2 0.02 51.19 Ileal perforation | 1 0.01 51.20 Ileus | 3 0.03 51.23 Ill-defined disorder | 7 0.07 51.30 Immune system disorder | 3 0.03 51.33 Immunodeficiency | 4 0.04 51.37 Immunosuppression | 1 0.01 51.38 Impaired driving ability | 2 0.02 51.40 Impaired gastric emptying | 2 0.02 51.42 Impaired healing | 11 0.11 51.53 Impaired insulin secretion | 1 0.01 51.54 Impaired work ability | 1 0.01 51.55 Impetigo | 1 0.01 51.56 Imprisonment | 1 0.01 51.57 Impulse-control disorder | 1 0.01 51.58 Inability to afford medication | 1 0.01 51.59 Inadequate analgesia | 1 0.01 51.60 Inappropriate affect | 1 0.01 51.61 Inappropriate antidiuretic hormone se.. | 1 0.01 51.62 Inappropriate schedule of drug admini.. | 14 0.14 51.76 Incision site haematoma | 1 0.01 51.77 Incision site haemorrhage | 2 0.02 51.79 Incisional drainage | 1 0.01 51.80 Incisional hernia | 1 0.01 51.81 Incontinence | 5 0.05 51.86 Incorrect dose administered | 10 0.10 51.96 Incorrect drug administration duration | 3 0.03 51.99 Incorrect drug administration rate | 1 0.01 52.00 Incorrect route of drug administration | 2 0.02 52.02 Increased appetite | 9 0.09 52.11 Increased bronchial secretion | 1 0.01 52.12 Increased tendency to bruise | 3 0.03 52.15 Increased upper airway secretion | 2 0.02 52.17 Induration | 2 0.02 52.19 Infarction | 1 0.01 52.20 Infected cyst | 1 0.01 52.21 Infection | 36 0.36 52.57 Infection susceptibility increased | 1 0.01 52.58 Infectious mononucleosis | 1 0.01 52.59 Infectious pleural effusion | 1 0.01 52.60 Infertility | 1 0.01 52.61 Infertility female | 1 0.01 52.62 Inflammation | 9 0.09 52.71 Inflammatory marker increased | 1 0.01 52.72 Influenza | 29 0.29 53.01 Influenza like illness | 11 0.11 53.12 Infusion related reaction | 7 0.07 53.19 Ingrowing nail | 2 0.02 53.21 Inguinal hernia | 5 0.05 53.26 Inguinal hernia repair | 1 0.01 53.27 Inhalation therapy | 1 0.01 53.28 Initial insomnia | 2 0.02 53.30 Injection site bruising | 6 0.06 53.36 Injection site cyst | 1 0.01 53.37 Injection site discolouration | 1 0.01 53.38 Injection site erythema | 4 0.04 53.42 Injection site haematoma | 1 0.01 53.43 Injection site haemorrhage | 7 0.07 53.50 Injection site hypertrophy | 1 0.01 53.51 Injection site induration | 2 0.02 53.53 Injection site mass | 3 0.03 53.56 Injection site pain | 31 0.31 53.87 Injection site pruritus | 4 0.04 53.91 Injection site rash | 1 0.01 53.92 Injection site reaction | 2 0.02 53.94 Injection site swelling | 4 0.04 53.98 Injection site urticaria | 1 0.01 53.99 Injection site vesicles | 1 0.01 54.00 Injury | 17 0.17 54.17 Inner ear disorder | 1 0.01 54.18 Insomnia | 48 0.48 54.66 Insulin resistant diabetes | 1 0.01 54.67 Insulin-like growth factor decreased | 8 0.08 54.75 Insulin-like growth factor increased | 15 0.15 54.90 Insurance issue | 2 0.02 54.92 Intellectual disability | 1 0.01 54.93 Intensive care | 1 0.01 54.94 Intentional device misuse | 1 0.01 54.95 Intentional overdose | 14 0.14 55.09 Intentional product misuse | 28 0.28 55.37 Intentional product use issue | 21 0.21 55.58 Intentional self-injury | 5 0.05 55.63 Internal haemorrhage | 3 0.03 55.66 Internal injury | 1 0.01 55.67 International normalised ratio increa.. | 3 0.03 55.70 Interstitial lung disease | 9 0.09 55.79 Intervertebral disc compression | 1 0.01 55.80 Intervertebral disc degeneration | 6 0.06 55.86 Intervertebral disc disorder | 2 0.02 55.88 Intervertebral disc protrusion | 5 0.05 55.93 Intervertebral discitis | 1 0.01 55.94 Intestinal diaphragm disease | 1 0.01 55.95 Intestinal fistula | 1 0.01 55.96 Intestinal haemorrhage | 4 0.04 56.00 Intestinal metaplasia | 1 0.01 56.01 Intestinal obstruction | 5 0.05 56.06 Intestinal perforation | 2 0.02 56.08 Intestinal polyp | 1 0.01 56.09 Intestinal pseudo-obstruction | 1 0.01 56.10 Intestinal stenosis | 1 0.01 56.11 Intracranial aneurysm | 5 0.05 56.16 Intracranial mass | 1 0.01 56.17 Intramedullary rod insertion | 4 0.04 56.21 Invasive ductal breast carcinoma | 4 0.04 56.25 Investigation abnormal | 1 0.01 56.26 Investigation noncompliance | 1 0.01 56.27 Iodine allergy | 1 0.01 56.28 Iris incarceration | 1 0.01 56.29 Iritis | 2 0.02 56.31 Iron deficiency | 1 0.01 56.32 Iron deficiency anaemia | 4 0.04 56.36 Iron overload | 1 0.01 56.37 Irritability | 5 0.05 56.42 Ischaemia | 1 0.01 56.43 Ischaemic cardiomyopathy | 1 0.01 56.44 JC polyomavirus test positive | 2 0.02 56.46 Jaundice | 4 0.04 56.50 Jaw disorder | 2 0.02 56.52 Jejunostomy | 1 0.01 56.53 Joint ankylosis | 1 0.01 56.54 Joint contracture | 1 0.01 56.55 Joint dislocation | 7 0.07 56.62 Joint dislocation postoperative | 1 0.01 56.63 Joint effusion | 4 0.04 56.67 Joint injury | 8 0.08 56.75 Joint lock | 2 0.02 56.77 Joint noise | 1 0.01 56.78 Joint range of motion decreased | 1 0.01 56.79 Joint stiffness | 5 0.05 56.84 Joint surgery | 1 0.01 56.85 Joint swelling | 19 0.19 57.04 Juvenile idiopathic arthritis | 1 0.01 57.05 Kaposi's sarcoma | 1 0.01 57.06 Kawasaki's disease | 1 0.01 57.07 Keloid scar | 1 0.01 57.08 Keratoacanthoma | 1 0.01 57.09 Keratosis pilaris | 1 0.01 57.10 Ketosis | 1 0.01 57.11 Kidney infection | 4 0.04 57.15 Kidney transplant rejection | 3 0.03 57.18 Klebsiella infection | 1 0.01 57.19 Knee arthroplasty | 3 0.03 57.22 Knee deformity | 2 0.02 57.24 Kyphoscoliosis | 1 0.01 57.25 Kyphosis | 1 0.01 57.26 Labelled drug-drug interaction medica.. | 3 0.03 57.29 Labile hypertension | 1 0.01 57.30 Laboratory test abnormal | 2 0.02 57.32 Labyrinthitis | 3 0.03 57.35 Laceration | 8 0.08 57.43 Lacrimation decreased | 1 0.01 57.44 Lacrimation increased | 7 0.07 57.51 Lactic acidosis | 1 0.01 57.52 Lagophthalmos | 1 0.01 57.53 Laparotomy | 1 0.01 57.54 Large for dates baby | 1 0.01 57.55 Large intestinal haemorrhage | 1 0.01 57.56 Large intestine polyp | 4 0.04 57.60 Laryngeal cancer | 1 0.01 57.61 Laryngeal haematoma | 1 0.01 57.62 Laryngeal pain | 2 0.02 57.64 Laryngitis | 4 0.04 57.68 Laziness | 1 0.01 57.69 Left atrial dilatation | 2 0.02 57.71 Left atrial enlargement | 1 0.01 57.72 Left ventricular dysfunction | 1 0.01 57.73 Left ventricular failure | 3 0.03 57.76 Left ventricular hypertrophy | 1 0.01 57.77 Leg amputation | 1 0.01 57.78 Lens capsulotomy | 1 0.01 57.79 Lens disorder | 1 0.01 57.80 Lesion excision | 1 0.01 57.81 Lethargy | 7 0.07 57.88 Leukaemia | 2 0.02 57.90 Leukaemia recurrent | 1 0.01 57.91 Leukocytosis | 2 0.02 57.93 Leukopenia | 10 0.10 58.03 Libido decreased | 3 0.03 58.06 Libido disorder | 1 0.01 58.07 Lichen planus | 1 0.01 58.08 Lid sulcus deepened | 1 0.01 58.09 Ligament sprain | 6 0.06 58.15 Limb asymmetry | 3 0.03 58.18 Limb discomfort | 12 0.12 58.30 Limb immobilisation | 1 0.01 58.31 Limb injury | 16 0.16 58.47 Limb mass | 2 0.02 58.49 Lip discolouration | 1 0.01 58.50 Lip erosion | 1 0.01 58.51 Lip infection | 2 0.02 58.53 Lip pruritus | 2 0.02 58.55 Lip swelling | 3 0.03 58.58 Lipase increased | 3 0.03 58.61 Lipids increased | 1 0.01 58.62 Lipohypertrophy | 1 0.01 58.63 Lipoma excision | 1 0.01 58.64 Liquid product physical issue | 1 0.01 58.65 Listeriosis | 1 0.01 58.66 Listless | 2 0.02 58.68 Live birth | 1 0.01 58.69 Liver function test abnormal | 3 0.03 58.72 Liver function test increased | 4 0.04 58.76 Liver injury | 1 0.01 58.77 Liver transplant | 1 0.01 58.78 Localised infection | 5 0.05 58.83 Localised oedema | 1 0.01 58.84 Loss of consciousness | 23 0.23 59.07 Loss of control of legs | 1 0.01 59.08 Loss of employment | 2 0.02 59.10 Loss of libido | 3 0.03 59.13 Loss of personal independence in dail.. | 10 0.10 59.23 Low birth weight baby | 1 0.01 59.24 Low density lipoprotein increased | 4 0.04 59.28 Low set ears | 1 0.01 59.29 Low turnover osteopathy | 9 0.09 59.38 Lower gastrointestinal haemorrhage | 1 0.01 59.39 Lower limb fracture | 9 0.09 59.48 Lower respiratory tract congestion | 2 0.02 59.50 Lower respiratory tract infection | 9 0.09 59.59 Lower respiratory tract inflammation | 1 0.01 59.60 Lower urinary tract symptoms | 1 0.01 59.61 Lumbar spinal stenosis | 1 0.01 59.62 Lumbar vertebral fracture | 3 0.03 59.65 Lumbosacral radiculopathy | 1 0.01 59.66 Lung cancer metastatic | 1 0.01 59.67 Lung disorder | 11 0.11 59.78 Lung hyperinflation | 1 0.01 59.79 Lung infection | 6 0.06 59.85 Lung infection pseudomonal | 1 0.01 59.86 Lung neoplasm malignant | 4 0.04 59.90 Lupus-like syndrome | 1 0.01 59.91 Lyme disease | 2 0.02 59.93 Lymphadenopathy | 5 0.05 59.98 Lymphadenopathy mediastinal | 1 0.01 59.99 Lymphocyte count decreased | 7 0.07 60.06 Lymphocyte count increased | 1 0.01 60.07 Lymphocytosis | 1 0.01 60.08 Lymphoedema | 2 0.02 60.10 Lymphoma | 3 0.03 60.13 Lymphopenia | 8 0.08 60.21 Lymphoproliferative disorder | 2 0.02 60.23 Macrocytosis | 2 0.02 60.25 Macular degeneration | 4 0.04 60.29 Macular oedema | 3 0.03 60.32 Macule | 2 0.02 60.34 Malaise | 88 0.88 61.22 Male genital examination abnormal | 1 0.01 61.23 Malignant hypertension | 1 0.01 61.24 Malignant melanoma | 7 0.07 61.31 Malignant melanoma in situ | 4 0.04 61.35 Malignant melanoma stage I | 1 0.01 61.36 Malignant neoplasm of ampulla of Vater | 1 0.01 61.37 Malignant neoplasm of spinal cord | 1 0.01 61.38 Malignant neoplasm progression | 13 0.13 61.51 Malignant peritoneal neoplasm | 1 0.01 61.52 Malnutrition | 3 0.03 61.55 Mammary duct ectasia | 1 0.01 61.56 Mania | 3 0.03 61.59 Mass | 4 0.04 61.63 Mastectomy | 1 0.01 61.64 Mastoiditis | 1 0.01 61.65 Maternal exposure before pregnancy | 2 0.02 61.67 Maternal exposure during breast feeding | 1 0.01 61.68 Maternal exposure during pregnancy | 13 0.13 61.81 Maternal exposure timing unspecified | 3 0.03 61.84 Mean cell haemoglobin concentration i.. | 1 0.01 61.85 Mean cell haemoglobin decreased | 1 0.01 61.86 Mean cell haemoglobin increased | 2 0.02 61.88 Mean cell volume increased | 1 0.01 61.89 Mechanical ventilation | 1 0.01 61.90 Mediastinal mass | 1 0.01 61.91 Medical device discomfort | 2 0.02 61.93 Medical device monitoring error | 1 0.01 61.94 Medical device pain | 1 0.01 61.95 Medical device removal | 1 0.01 61.96 Medical device site joint infection | 1 0.01 61.97 Medical procedure | 1 0.01 61.98 Medication error | 5 0.05 62.03 Melaena | 3 0.03 62.06 Melanocytic naevus | 4 0.04 62.10 Memory impairment | 36 0.36 62.46 Meningitis | 1 0.01 62.47 Meningitis meningococcal | 1 0.01 62.48 Meningitis mumps | 1 0.01 62.49 Meningococcal sepsis | 3 0.03 62.52 Meniscus removal | 1 0.01 62.53 Menopausal symptoms | 1 0.01 62.54 Menopause | 1 0.01 62.55 Menorrhagia | 3 0.03 62.58 Menstruation irregular | 1 0.01 62.59 Mental disorder | 7 0.07 62.66 Mental fatigue | 1 0.01 62.67 Mental impairment | 4 0.04 62.71 Mental status changes | 5 0.05 62.76 Metabolic acidosis | 3 0.03 62.79 Metabolic disorder | 1 0.01 62.80 Metapneumovirus infection | 1 0.01 62.81 Metastases to bone | 2 0.02 62.83 Metastases to central nervous system | 2 0.02 62.85 Metastases to liver | 2 0.02 62.87 Metastases to lung | 3 0.03 62.90 Metastases to lymph nodes | 3 0.03 62.93 Metastases to peritoneum | 1 0.01 62.94 Metastasis | 2 0.02 62.96 Metastatic carcinoid tumour | 1 0.01 62.97 Metastatic neoplasm | 2 0.02 62.99 Metastatic renal cell carcinoma | 3 0.03 63.02 Metastatic squamous cell carcinoma | 1 0.01 63.03 Microangiopathic haemolytic anaemia | 1 0.01 63.04 Micrognathia | 1 0.01 63.05 Micturition urgency | 3 0.03 63.08 Middle ear effusion | 1 0.01 63.09 Middle insomnia | 3 0.03 63.12 Migraine | 15 0.15 63.27 Migraine with aura | 2 0.02 63.29 Mitochondrial cytopathy | 1 0.01 63.30 Mitral valve incompetence | 3 0.03 63.33 Mitral valve prolapse | 2 0.02 63.35 Mitral valve repair | 1 0.01 63.36 Mobility decreased | 7 0.07 63.43 Monocyte count decreased | 1 0.01 63.44 Monocyte count increased | 4 0.04 63.48 Mood altered | 6 0.06 63.54 Mood swings | 5 0.05 63.59 Motor dysfunction | 1 0.01 63.60 Mouth haemorrhage | 1 0.01 63.61 Mouth swelling | 2 0.02 63.63 Mouth ulceration | 4 0.04 63.67 Movement disorder | 7 0.07 63.74 Mucinous breast carcinoma | 1 0.01 63.75 Mucosal dryness | 1 0.01 63.76 Mucosal inflammation | 12 0.12 63.88 Multiple allergies | 1 0.01 63.89 Multiple fractures | 1 0.01 63.90 Multiple injuries | 1 0.01 63.91 Multiple organ dysfunction syndrome | 9 0.09 64.00 Multiple sclerosis | 9 0.09 64.09 Multiple sclerosis relapse | 14 0.14 64.23 Muscle atrophy | 3 0.03 64.26 Muscle contracture | 1 0.01 64.27 Muscle disorder | 3 0.03 64.30 Muscle fatigue | 1 0.01 64.31 Muscle injury | 1 0.01 64.32 Muscle rigidity | 3 0.03 64.35 Muscle rupture | 1 0.01 64.36 Muscle spasms | 27 0.27 64.63 Muscle spasticity | 1 0.01 64.64 Muscle strain | 4 0.04 64.68 Muscle swelling | 1 0.01 64.69 Muscle tightness | 3 0.03 64.72 Muscle twitching | 2 0.02 64.74 Muscular weakness | 28 0.28 65.02 Musculoskeletal chest pain | 2 0.02 65.04 Musculoskeletal discomfort | 1 0.01 65.05 Musculoskeletal disorder | 6 0.06 65.11 Musculoskeletal pain | 12 0.12 65.23 Musculoskeletal stiffness | 10 0.10 65.33 Myalgia | 36 0.36 65.69 Mycobacterial infection | 1 0.01 65.70 Mycobacterium avium complex infection | 1 0.01 65.71 Mydriasis | 2 0.02 65.73 Myelitis transverse | 1 0.01 65.74 Myelodysplastic syndrome | 4 0.04 65.78 Myocardial bridging | 1 0.01 65.79 Myocardial infarction | 30 0.30 66.09 Myocardial ischaemia | 4 0.04 66.13 Myocardial rupture | 1 0.01 66.14 Myocarditis | 1 0.01 66.15 Myoglobin blood increased | 1 0.01 66.16 Myopathy | 2 0.02 66.18 Myopia | 1 0.01 66.19 Myositis | 1 0.01 66.20 Naevus flammeus | 4 0.04 66.24 Nail disorder | 1 0.01 66.25 Nail operation | 1 0.01 66.26 Nasal congestion | 14 0.14 66.40 Nasal discomfort | 2 0.02 66.42 Nasal disorder | 1 0.01 66.43 Nasal injury | 1 0.01 66.44 Nasal obstruction | 2 0.02 66.46 Nasal polyps | 2 0.02 66.48 Nasal pruritus | 1 0.01 66.49 Nasal septum deviation | 1 0.01 66.50 Nasal turbinate hypertrophy | 1 0.01 66.51 Nasopharyngeal cancer | 2 0.02 66.53 Nasopharyngitis | 37 0.37 66.90 Nausea | 83 0.83 67.73 Neck injury | 1 0.01 67.74 Neck pain | 7 0.07 67.81 Necrosis | 1 0.01 67.82 Needle issue | 3 0.03 67.85 Negative thoughts | 1 0.01 67.86 Neoplasm | 3 0.03 67.89 Neoplasm malignant | 9 0.09 67.98 Neoplasm progression | 5 0.05 68.03 Neoplasm recurrence | 2 0.02 68.05 Nephrectomy | 1 0.01 68.06 Nephrolithiasis | 15 0.15 68.21 Nephropathy toxic | 1 0.01 68.22 Nephrotic syndrome | 1 0.01 68.23 Nerve injury | 4 0.04 68.27 Nervous system disorder | 6 0.06 68.33 Nervousness | 13 0.13 68.46 Neuralgia | 7 0.07 68.53 Neuroblastoma | 1 0.01 68.54 Neurogenic bladder | 1 0.01 68.55 Neuroleptic malignant syndrome | 5 0.05 68.60 Neurological symptom | 1 0.01 68.61 Neuromuscular block prolonged | 1 0.01 68.62 Neuropathy peripheral | 16 0.16 68.78 Neurotoxicity | 2 0.02 68.80 Neutralising antibodies positive | 1 0.01 68.81 Neutropenia | 24 0.24 69.05 Neutropenic colitis | 1 0.01 69.06 Neutropenic infection | 2 0.02 69.08 Neutropenic sepsis | 2 0.02 69.10 Neutrophil count abnormal | 1 0.01 69.11 Neutrophil count decreased | 5 0.05 69.16 Neutrophil count increased | 4 0.04 69.20 Neutrophil percentage increased | 1 0.01 69.21 Neutrophilia | 2 0.02 69.23 Night sweats | 5 0.05 69.28 Nightmare | 11 0.11 69.39 No adverse event | 4 0.04 69.43 Nocturia | 5 0.05 69.48 Nodule | 5 0.05 69.53 Non-small cell lung cancer | 1 0.01 69.54 Noninfective gingivitis | 1 0.01 69.55 Nuchal rigidity | 1 0.01 69.56 Nystagmus | 2 0.02 69.58 Obesity | 6 0.06 69.64 Obliterative bronchiolitis | 1 0.01 69.65 Obsessive-compulsive disorder | 3 0.03 69.68 Obstruction gastric | 1 0.01 69.69 Obstructive airways disorder | 1 0.01 69.70 Ocular discomfort | 1 0.01 69.71 Ocular hyperaemia | 3 0.03 69.74 Ocular myasthenia | 1 0.01 69.75 Oculogyric crisis | 1 0.01 69.76 Oculomucocutaneous syndrome | 1 0.01 69.77 Odynophagia | 1 0.01 69.78 Oedema | 18 0.18 69.96 Oedema peripheral | 13 0.13 70.09 Oesophageal adenocarcinoma | 1 0.01 70.10 Oesophageal candidiasis | 1 0.01 70.11 Oesophageal carcinoma | 2 0.02 70.13 Oesophageal discomfort | 1 0.01 70.14 Oesophageal disorder | 1 0.01 70.15 Oesophageal haemorrhage | 1 0.01 70.16 Oesophageal perforation | 2 0.02 70.18 Oesophageal spasm | 4 0.04 70.22 Oesophageal ulcer | 1 0.01 70.23 Oesophagitis | 4 0.04 70.27 Oestrogen deficiency | 1 0.01 70.28 Oestrogen receptor positive breast ca.. | 1 0.01 70.29 Off label use | 70 0.70 70.99 Oligohydramnios | 2 0.02 71.01 Oligomenorrhoea | 1 0.01 71.02 Oophorectomy | 3 0.03 71.05 Open reduction of fracture | 3 0.03 71.08 Opiates positive | 1 0.01 71.09 Oral candidiasis | 1 0.01 71.10 Oral cavity fistula | 1 0.01 71.11 Oral discharge | 1 0.01 71.12 Oral discomfort | 1 0.01 71.13 Oral disorder | 5 0.05 71.18 Oral herpes | 2 0.02 71.20 Oral mucosal blistering | 1 0.01 71.21 Oral mucosal discolouration | 1 0.01 71.22 Oral mucosal eruption | 1 0.01 71.23 Oral pain | 3 0.03 71.26 Oral pruritus | 1 0.01 71.27 Oral surgery | 1 0.01 71.28 Organic erectile dysfunction | 3 0.03 71.31 Orgasm abnormal | 1 0.01 71.32 Orgasmic sensation decreased | 1 0.01 71.33 Oropharyngeal discomfort | 1 0.01 71.34 Oropharyngeal pain | 18 0.18 71.52 Oropharyngeal squamous cell carcinoma | 1 0.01 71.53 Orthostatic hypotension | 3 0.03 71.56 Osteitis | 2 0.02 71.58 Osteoarthritis | 32 0.32 71.90 Osteochondrosis | 2 0.02 71.92 Osteolysis | 2 0.02 71.94 Osteomalacia | 1 0.01 71.95 Osteomyelitis | 6 0.06 72.01 Osteonecrosis | 5 0.05 72.06 Osteonecrosis of jaw | 11 0.11 72.17 Osteopenia | 5 0.05 72.22 Osteopetrosis | 1 0.01 72.23 Osteoporosis | 24 0.24 72.47 Osteosclerosis | 1 0.01 72.48 Otitis externa | 1 0.01 72.49 Otitis media | 2 0.02 72.51 Otitis media chronic | 1 0.01 72.52 Otorrhoea | 1 0.01 72.53 Ovarian cancer | 2 0.02 72.55 Ovarian cancer stage IV | 1 0.01 72.56 Ovarian cyst | 2 0.02 72.58 Overdose | 15 0.15 72.73 Overweight | 5 0.05 72.78 Oxygen consumption decreased | 1 0.01 72.79 Oxygen consumption increased | 1 0.01 72.80 Oxygen saturation decreased | 7 0.07 72.87 Pain | 105 1.05 73.92 Pain in extremity | 62 0.62 74.54 Pain in jaw | 2 0.02 74.56 Pain of skin | 3 0.03 74.59 Pallor | 2 0.02 74.61 Palmar-plantar erythrodysaesthesia sy.. | 3 0.03 74.64 Palpitations | 20 0.20 74.84 Pancreatic carcinoma | 4 0.04 74.88 Pancreatitis | 5 0.05 74.93 Pancreatitis acute | 7 0.07 75.00 Pancytopenia | 5 0.05 75.05 Panic attack | 2 0.02 75.07 Panic disorder | 2 0.02 75.09 Panic reaction | 1 0.01 75.10 Paraesthesia | 18 0.18 75.28 Paraesthesia oral | 1 0.01 75.29 Paranasal sinus discomfort | 3 0.03 75.32 Paranoia | 7 0.07 75.39 Paraplegia | 2 0.02 75.41 Parathyroidectomy | 1 0.01 75.42 Parkinson's disease | 1 0.01 75.43 Parkinsonism | 3 0.03 75.46 Paronychia | 1 0.01 75.47 Parosmia | 1 0.01 75.48 Parotid gland enlargement | 1 0.01 75.49 Partial seizures | 2 0.02 75.51 Patella fracture | 2 0.02 75.53 Patellofemoral pain syndrome | 1 0.01 75.54 Pathological fracture | 1 0.01 75.55 Patient-device incompatibility | 2 0.02 75.57 Peau d'orange | 1 0.01 75.58 Pelvic abscess | 1 0.01 75.59 Pelvic floor dyssynergia | 1 0.01 75.60 Pelvic fracture | 2 0.02 75.62 Pelvic infection | 1 0.01 75.63 Pelvic pain | 6 0.06 75.69 Pelvic prolapse | 1 0.01 75.70 Pemphigoid | 1 0.01 75.71 Pemphigus | 1 0.01 75.72 Penile pain | 1 0.01 75.73 Penile size reduced | 1 0.01 75.74 Penis disorder | 3 0.03 75.77 Peptic ulcer | 1 0.01 75.78 Performance status decreased | 2 0.02 75.80 Perfume sensitivity | 1 0.01 75.81 Pericardial effusion | 6 0.06 75.87 Pericardial haemorrhage | 2 0.02 75.89 Pericarditis | 1 0.01 75.90 Perineal infection | 1 0.01 75.91 Periodontitis | 1 0.01 75.92 Periorbital haemorrhage | 1 0.01 75.93 Periorbital oedema | 1 0.01 75.94 Peripheral arterial occlusive disease | 1 0.01 75.95 Peripheral artery occlusion | 1 0.01 75.96 Peripheral coldness | 1 0.01 75.97 Peripheral paralysis | 1 0.01 75.98 Peripheral sensory neuropathy | 4 0.04 76.02 Peripheral swelling | 30 0.30 76.32 Peripheral vascular disorder | 3 0.03 76.35 Peripheral venous disease | 1 0.01 76.36 Periprosthetic fracture | 1 0.01 76.37 Peritoneal adhesions | 1 0.01 76.38 Peritoneal haemorrhage | 1 0.01 76.39 Peritoneal tuberculosis | 1 0.01 76.40 Peritonitis | 4 0.04 76.44 Pernicious anaemia | 1 0.01 76.45 Peroneal nerve palsy | 3 0.03 76.48 Persistent depressive disorder | 1 0.01 76.49 Personality change | 3 0.03 76.52 Personality disorder | 2 0.02 76.54 Pertussis | 1 0.01 76.55 Petechiae | 1 0.01 76.56 Peyronie's disease | 1 0.01 76.57 Pharyngeal haematoma | 1 0.01 76.58 Pharyngeal inflammation | 1 0.01 76.59 Pharyngeal paraesthesia | 1 0.01 76.60 Pharyngitis | 8 0.08 76.68 Phlebitis | 1 0.01 76.69 Phobia | 1 0.01 76.70 Phonophobia | 1 0.01 76.71 Photophobia | 3 0.03 76.74 Photosensitivity reaction | 1 0.01 76.75 Pineal gland cyst | 1 0.01 76.76 Pituitary tumour | 2 0.02 76.78 Pituitary tumour benign | 1 0.01 76.79 Pityriasis rosea | 1 0.01 76.80 Placental chorioangioma | 1 0.01 76.81 Placental infarction | 1 0.01 76.82 Plantar fasciitis | 2 0.02 76.84 Plasma cell leukaemia | 1 0.01 76.85 Plasma cell myeloma | 5 0.05 76.90 Platelet count abnormal | 1 0.01 76.91 Platelet count decreased | 8 0.08 76.99 Platelet count increased | 4 0.04 77.03 Pleural effusion | 10 0.10 77.13 Pleuritic pain | 1 0.01 77.14 Pneumocystis jirovecii pneumonia | 1 0.01 77.15 Pneumonia | 56 0.56 77.71 Pneumonia aspiration | 4 0.04 77.75 Pneumonia bacterial | 2 0.02 77.77 Pneumonia legionella | 1 0.01 77.78 Pneumonia pseudomonal | 1 0.01 77.79 Pneumonitis | 1 0.01 77.80 Pneumonitis chemical | 1 0.01 77.81 Pneumothorax | 1 0.01 77.82 Poisoning deliberate | 1 0.01 77.83 Pollakiuria | 8 0.08 77.91 Polyarthritis | 2 0.02 77.93 Polydipsia | 4 0.04 77.97 Polyneuropathy | 1 0.01 77.98 Polyp | 4 0.04 78.02 Polyuria | 5 0.05 78.07 Poor peripheral circulation | 1 0.01 78.08 Poor quality drug administered | 1 0.01 78.09 Poor quality sleep | 4 0.04 78.13 Portal vein thrombosis | 1 0.01 78.14 Post concussion syndrome | 1 0.01 78.15 Post herpetic neuralgia | 1 0.01 78.16 Post procedural bile leak | 1 0.01 78.17 Post procedural complication | 7 0.07 78.24 Post procedural diarrhoea | 1 0.01 78.25 Post procedural fistula | 1 0.01 78.26 Post procedural haematoma | 3 0.03 78.29 Post procedural haemorrhage | 3 0.03 78.32 Post procedural hypothyroidism | 1 0.01 78.33 Post procedural infection | 3 0.03 78.36 Post procedural inflammation | 1 0.01 78.37 Post-traumatic neck syndrome | 1 0.01 78.38 Post-traumatic stress disorder | 4 0.04 78.42 Posterior reversible encephalopathy s.. | 3 0.03 78.45 Postoperative respiratory distress | 1 0.01 78.46 Postoperative respiratory failure | 1 0.01 78.47 Postoperative wound complication | 1 0.01 78.48 Postoperative wound infection | 2 0.02 78.50 Postprandial hypoglycaemia | 1 0.01 78.51 Postural tremor | 1 0.01 78.52 Potentiating drug interaction | 1 0.01 78.53 Precancerous mucosal lesion | 1 0.01 78.54 Pregnancy | 2 0.02 78.56 Pregnancy on oral contraceptive | 1 0.01 78.57 Pregnancy with contraceptive device | 5 0.05 78.62 Pregnancy with implant contraceptive | 1 0.01 78.63 Premature baby | 6 0.06 78.69 Premature delivery | 4 0.04 78.73 Premature ejaculation | 1 0.01 78.74 Premature labour | 1 0.01 78.75 Premature rupture of membranes | 1 0.01 78.76 Presbyopia | 1 0.01 78.77 Prescribed overdose | 2 0.02 78.79 Prescribed underdose | 1 0.01 78.80 Presyncope | 6 0.06 78.86 Priapism | 2 0.02 78.88 Primary sequestrum | 2 0.02 78.90 Prinzmetal angina | 1 0.01 78.91 Procedural complication | 2 0.02 78.93 Procedural haemorrhage | 1 0.01 78.94 Procedural hypotension | 1 0.01 78.95 Procedural intestinal perforation | 1 0.01 78.96 Procedural pain | 5 0.05 79.01 Proctitis | 1 0.01 79.02 Product adhesion issue | 1 0.01 79.03 Product label confusion | 2 0.02 79.05 Product packaging issue | 2 0.02 79.07 Product packaging quantity issue | 1 0.01 79.08 Product quality control issue | 1 0.01 79.09 Product quality issue | 17 0.17 79.26 Product storage error | 2 0.02 79.28 Product substitution issue | 1 0.01 79.29 Product supply issue | 1 0.01 79.30 Product use in unapproved indication | 29 0.29 79.59 Product use issue | 16 0.16 79.75 Productive cough | 8 0.08 79.83 Progressive multifocal leukoencephalo.. | 4 0.04 79.87 Prolonged expiration | 1 0.01 79.88 Prominent epicanthal folds | 1 0.01 79.89 Prostate cancer | 4 0.04 79.93 Prostatic specific antigen increased | 1 0.01 79.94 Prostatomegaly | 2 0.02 79.96 Protein deficiency | 1 0.01 79.97 Protein total increased | 2 0.02 79.99 Protein urine | 1 0.01 80.00 Proteinuria | 3 0.03 80.03 Pruritus | 30 0.30 80.33 Pruritus allergic | 1 0.01 80.34 Pruritus generalised | 5 0.05 80.39 Pseudocholelithiasis | 3 0.03 80.42 Pseudohyperkalaemia | 1 0.01 80.43 Pseudomembranous colitis | 1 0.01 80.44 Pseudomonas infection | 1 0.01 80.45 Pseudoporphyria | 1 0.01 80.46 Psoriasis | 9 0.09 80.55 Psoriatic arthropathy | 3 0.03 80.58 Psychiatric decompensation | 2 0.02 80.60 Psychiatric symptom | 2 0.02 80.62 Psychological trauma | 2 0.02 80.64 Psychomotor hyperactivity | 2 0.02 80.66 Psychomotor skills impaired | 1 0.01 80.67 Psychosexual disorder | 1 0.01 80.68 Psychotic disorder | 11 0.11 80.79 Pulmonary arterial hypertension | 2 0.02 80.81 Pulmonary arterial pressure increased | 1 0.01 80.82 Pulmonary congestion | 4 0.04 80.86 Pulmonary embolism | 21 0.21 81.07 Pulmonary fibrosis | 4 0.04 81.11 Pulmonary function test decreased | 2 0.02 81.13 Pulmonary granuloma | 1 0.01 81.14 Pulmonary haemorrhage | 2 0.02 81.16 Pulmonary hypertension | 5 0.05 81.21 Pulmonary infarction | 2 0.02 81.23 Pulmonary mass | 6 0.06 81.29 Pulmonary oedema | 15 0.15 81.44 Pulmonary resection | 1 0.01 81.45 Pulmonary tuberculosis | 1 0.01 81.46 Pulmonary valve stenosis | 1 0.01 81.47 Pulmonary valve stenosis congenital | 1 0.01 81.48 Pulse abnormal | 1 0.01 81.49 Pupillary reflex impaired | 2 0.02 81.51 Purpura | 1 0.01 81.52 Purulent discharge | 1 0.01 81.53 Pyelonephritis | 1 0.01 81.54 Pyelonephritis acute | 1 0.01 81.55 Pyloric stenosis | 1 0.01 81.56 Pyloromyotomy | 1 0.01 81.57 Pyrexia | 62 0.62 82.19 Quality of life decreased | 1 0.01 82.20 Radial nerve compression | 1 0.01 82.21 Radiation larynx injury | 1 0.01 82.22 Radicular pain | 1 0.01 82.23 Radius fracture | 3 0.03 82.26 Rales | 2 0.02 82.28 Rapid eye movements sleep abnormal | 1 0.01 82.29 Rash | 39 0.39 82.68 Rash erythematous | 5 0.05 82.73 Rash generalised | 4 0.04 82.77 Rash macular | 6 0.06 82.83 Rash papular | 2 0.02 82.85 Rash pruritic | 5 0.05 82.90 Rash pustular | 1 0.01 82.91 Raynaud's phenomenon | 2 0.02 82.93 Rebound effect | 1 0.01 82.94 Recall phenomenon | 1 0.01 82.95 Rectal abscess | 1 0.01 82.96 Rectal adenocarcinoma | 2 0.02 82.98 Rectal haemorrhage | 6 0.06 83.04 Rectal prolapse | 1 0.01 83.05 Rectocele | 1 0.01 83.06 Recurrence of neuromuscular blockade | 1 0.01 83.07 Red blood cell count decreased | 6 0.06 83.13 Red blood cell count increased | 1 0.01 83.14 Red blood cell sedimentation rate inc.. | 3 0.03 83.17 Red cell distribution width increased | 1 0.01 83.18 Refusal of treatment by patient | 1 0.01 83.19 Regurgitation | 3 0.03 83.22 Renal artery thrombosis | 1 0.01 83.23 Renal atrophy | 1 0.01 83.24 Renal cancer | 3 0.03 83.27 Renal cancer metastatic | 1 0.01 83.28 Renal cell carcinoma | 2 0.02 83.30 Renal colic | 2 0.02 83.32 Renal cyst | 2 0.02 83.34 Renal disorder | 14 0.14 83.48 Renal failure | 14 0.14 83.62 Renal impairment | 11 0.11 83.73 Renal injury | 1 0.01 83.74 Renal mass | 1 0.01 83.75 Renal stone removal | 1 0.01 83.76 Renal transplant | 1 0.01 83.77 Renal tubular disorder | 1 0.01 83.78 Renal tubular necrosis | 3 0.03 83.81 Reproductive tract disorder | 1 0.01 83.82 Respiratory arrest | 3 0.03 83.85 Respiratory depression | 1 0.01 83.86 Respiratory disorder | 10 0.10 83.96 Respiratory distress | 6 0.06 84.02 Respiratory failure | 18 0.18 84.20 Respiratory rate increased | 1 0.01 84.21 Respiratory tract congestion | 3 0.03 84.24 Respiratory tract infection | 5 0.05 84.29 Restless legs syndrome | 5 0.05 84.34 Restlessness | 8 0.08 84.42 Retching | 1 0.01 84.43 Retinal detachment | 1 0.01 84.44 Retinal haemorrhage | 2 0.02 84.46 Retinal tear | 3 0.03 84.49 Retinal vein occlusion | 1 0.01 84.50 Retinoblastoma | 1 0.01 84.51 Retroperitoneal haemorrhage | 1 0.01 84.52 Reversible airways obstruction | 1 0.01 84.53 Rhabdomyolysis | 5 0.05 84.58 Rheumatic disorder | 1 0.01 84.59 Rheumatoid arthritis | 22 0.22 84.81 Rheumatoid vasculitis | 1 0.01 84.82 Rhinitis | 5 0.05 84.87 Rhinitis allergic | 4 0.04 84.91 Rhinoplasty | 1 0.01 84.92 Rhinorrhoea | 5 0.05 84.97 Rhinovirus infection | 1 0.01 84.98 Rib fracture | 8 0.08 85.06 Rickets | 1 0.01 85.07 Right atrial dilatation | 1 0.01 85.08 Right ventricular failure | 3 0.03 85.11 Right ventricular hypertrophy | 2 0.02 85.13 Right ventricular systolic pressure i.. | 1 0.01 85.14 Road traffic accident | 10 0.10 85.24 Rosai-Dorfman syndrome | 1 0.01 85.25 Rotator cuff syndrome | 3 0.03 85.28 Rubber sensitivity | 1 0.01 85.29 Ruptured ectopic pregnancy | 1 0.01 85.30 Salpingo-oophorectomy | 1 0.01 85.31 Sarcoidosis | 2 0.02 85.33 Scab | 3 0.03 85.36 Scar | 5 0.05 85.41 Schizoaffective disorder | 2 0.02 85.43 Schizophrenia | 4 0.04 85.47 Sciatica | 3 0.03 85.50 Scoliosis | 7 0.07 85.57 Scratch | 2 0.02 85.59 Scrotal disorder | 1 0.01 85.60 Seasonal allergy | 4 0.04 85.64 Seborrhoea | 1 0.01 85.65 Seborrhoeic dermatitis | 2 0.02 85.67 Seborrhoeic keratosis | 1 0.01 85.68 Second primary malignancy | 2 0.02 85.70 Secondary hypogonadism | 1 0.01 85.71 Secondary progressive multiple sclero.. | 1 0.01 85.72 Secretion discharge | 1 0.01 85.73 Sedation | 4 0.04 85.77 Seizure | 24 0.24 86.01 Seizure like phenomena | 1 0.01 86.02 Selective IgA immunodeficiency | 1 0.01 86.03 Self esteem decreased | 1 0.01 86.04 Senile dementia | 1 0.01 86.05 Sensation of foreign body | 1 0.01 86.06 Sensitisation | 1 0.01 86.07 Sensitivity to weather change | 2 0.02 86.09 Sensory disturbance | 4 0.04 86.13 Sensory loss | 3 0.03 86.16 Sepsis | 19 0.19 86.35 Sepsis syndrome | 1 0.01 86.36 Septic shock | 15 0.15 86.51 Seroma | 1 0.01 86.52 Serotonin syndrome | 2 0.02 86.54 Serum ferritin increased | 1 0.01 86.55 Sex hormone binding globulin decreased | 1 0.01 86.56 Sexual dysfunction | 5 0.05 86.61 Shock | 2 0.02 86.63 Shock haemorrhagic | 1 0.01 86.64 Shoulder deformity | 1 0.01 86.65 Shoulder operation | 1 0.01 86.66 Sinus bradycardia | 4 0.04 86.70 Sinus congestion | 1 0.01 86.71 Sinus disorder | 3 0.03 86.74 Sinus headache | 1 0.01 86.75 Sinus operation | 1 0.01 86.76 Sinus polyp | 1 0.01 86.77 Sinus tachycardia | 1 0.01 86.78 Sinusitis | 17 0.17 86.95 Sinusitis fungal | 1 0.01 86.96 Sjogren's syndrome | 3 0.03 86.99 Skin abrasion | 2 0.02 87.01 Skin burning sensation | 1 0.01 87.02 Skin cancer | 8 0.08 87.10 Skin discolouration | 6 0.06 87.16 Skin disorder | 5 0.05 87.21 Skin erosion | 1 0.01 87.22 Skin exfoliation | 2 0.02 87.24 Skin haemorrhage | 2 0.02 87.26 Skin hypertrophy | 1 0.01 87.27 Skin induration | 2 0.02 87.29 Skin infection | 3 0.03 87.32 Skin irritation | 1 0.01 87.33 Skin lesion | 5 0.05 87.38 Skin malformation | 1 0.01 87.39 Skin mass | 1 0.01 87.40 Skin necrosis | 1 0.01 87.41 Skin odour abnormal | 3 0.03 87.44 Skin reaction | 2 0.02 87.46 Skin sensitisation | 1 0.01 87.47 Skin striae | 3 0.03 87.50 Skin ulcer | 7 0.07 87.57 Skin warm | 1 0.01 87.58 Sleep apnoea syndrome | 6 0.06 87.64 Sleep disorder | 17 0.17 87.81 Sleep disorder due to a general medic.. | 1 0.01 87.82 Slow speech | 1 0.01 87.83 Sluggishness | 3 0.03 87.86 Small for dates baby | 2 0.02 87.88 Small intestinal obstruction | 2 0.02 87.90 Small intestinal resection | 1 0.01 87.91 Small intestinal stenosis | 2 0.02 87.93 Sneezing | 5 0.05 87.98 Snoring | 1 0.01 87.99 Social fear | 1 0.01 88.00 Soft tissue disorder | 1 0.01 88.01 Soft tissue infection | 1 0.01 88.02 Somnambulism | 2 0.02 88.04 Somnolence | 14 0.14 88.18 Sopor | 2 0.02 88.20 Speech disorder | 18 0.18 88.38 Speech disorder developmental | 2 0.02 88.40 Spinal claudication | 1 0.01 88.41 Spinal column stenosis | 4 0.04 88.45 Spinal compression fracture | 2 0.02 88.47 Spinal deformity | 2 0.02 88.49 Spinal disorder | 5 0.05 88.54 Spinal fracture | 2 0.02 88.56 Spinal fusion surgery | 3 0.03 88.59 Spinal operation | 2 0.02 88.61 Spinal osteoarthritis | 6 0.06 88.67 Spinal pain | 2 0.02 88.69 Spirometry abnormal | 1 0.01 88.70 Splenic granuloma | 1 0.01 88.71 Splenomegaly | 1 0.01 88.72 Spondylolisthesis | 3 0.03 88.75 Sprue-like enteropathy | 1 0.01 88.76 Sputum discoloured | 2 0.02 88.78 Squamous cell carcinoma | 8 0.08 88.86 Squamous cell carcinoma of skin | 3 0.03 88.89 Squamous cell carcinoma of the cervix | 1 0.01 88.90 Squamous cell carcinoma of the tongue | 1 0.01 88.91 Staphylococcal infection | 7 0.07 88.98 Staphylococcal sepsis | 1 0.01 88.99 Staphylococcal skin infection | 1 0.01 89.00 Status epilepticus | 5 0.05 89.05 Stereotypy | 1 0.01 89.06 Stevens-Johnson syndrome | 2 0.02 89.08 Stillbirth | 1 0.01 89.09 Stomatitis | 16 0.16 89.25 Strabismus | 1 0.01 89.26 Stress | 19 0.19 89.45 Stress at work | 2 0.02 89.47 Stress cardiomyopathy | 1 0.01 89.48 Stress fracture | 5 0.05 89.53 Stress urinary incontinence | 1 0.01 89.54 Stricturoplasty | 1 0.01 89.55 Stridor | 1 0.01 89.56 Subarachnoid haemorrhage | 1 0.01 89.57 Subchondral insufficiency fracture | 1 0.01 89.58 Subcutaneous abscess | 2 0.02 89.60 Subcutaneous haematoma | 1 0.01 89.61 Subdural empyema | 1 0.01 89.62 Subdural haematoma | 1 0.01 89.63 Submaxillary gland enlargement | 1 0.01 89.64 Subretinal fluid | 1 0.01 89.65 Substance abuse | 2 0.02 89.67 Sudden cardiac death | 1 0.01 89.68 Sudden death | 4 0.04 89.72 Suicidal behaviour | 1 0.01 89.73 Suicidal ideation | 9 0.09 89.82 Suicide attempt | 12 0.12 89.94 Sunburn | 1 0.01 89.95 Supraventricular extrasystoles | 3 0.03 89.98 Supraventricular tachycardia | 3 0.03 90.01 Surgery | 6 0.06 90.07 Surgical failure | 1 0.01 90.08 Suspected counterfeit product | 2 0.02 90.10 Swelling | 22 0.22 90.32 Swelling face | 3 0.03 90.35 Swollen joint count increased | 1 0.01 90.36 Swollen tongue | 5 0.05 90.41 Syncope | 10 0.10 90.51 Synovial cyst | 2 0.02 90.53 Systemic inflammatory response syndrome | 2 0.02 90.55 Systemic lupus erythematosus | 2 0.02 90.57 Systemic mycosis | 1 0.01 90.58 T-lymphocyte count decreased | 1 0.01 90.59 Tachyarrhythmia | 1 0.01 90.60 Tachycardia | 10 0.10 90.70 Tearfulness | 1 0.01 90.71 Temperature intolerance | 7 0.07 90.78 Temperature regulation disorder | 2 0.02 90.80 Temporomandibular joint syndrome | 1 0.01 90.81 Tenderness | 3 0.03 90.84 Tendon disorder | 1 0.01 90.85 Tendon pain | 1 0.01 90.86 Tendon rupture | 2 0.02 90.88 Tendon sheath incision | 1 0.01 90.89 Tendonitis | 1 0.01 90.90 Tenoplasty | 1 0.01 90.91 Tenosynovitis | 2 0.02 90.93 Tension | 1 0.01 90.94 Testicular atrophy | 1 0.01 90.95 Testicular failure | 1 0.01 90.96 Testicular pain | 2 0.02 90.98 Tetanus | 2 0.02 91.00 Tetany | 2 0.02 91.02 Thalamus haemorrhage | 1 0.01 91.03 Therapeutic product ineffective | 1 0.01 91.04 Therapeutic reaction time decreased | 1 0.01 91.05 Therapeutic response decreased | 5 0.05 91.10 Therapeutic response unexpected | 11 0.11 91.21 Therapy cessation | 15 0.15 91.36 Therapy non-responder | 3 0.03 91.39 Thermal burn | 2 0.02 91.41 Thinking abnormal | 4 0.04 91.45 Thirst | 4 0.04 91.49 Thoracic vertebral fracture | 2 0.02 91.51 Throat cancer | 2 0.02 91.53 Throat irritation | 6 0.06 91.59 Throat tightness | 2 0.02 91.61 Thrombocytopenia | 34 0.34 91.95 Thrombocytosis | 1 0.01 91.96 Thrombosis | 18 0.18 92.14 Thrombotic microangiopathy | 1 0.01 92.15 Thrombotic stroke | 2 0.02 92.17 Thrombotic thrombocytopenic purpura | 3 0.03 92.20 Thyroid cancer | 1 0.01 92.21 Thyroid cyst | 1 0.01 92.22 Thyroid disorder | 5 0.05 92.27 Thyroid function test abnormal | 1 0.01 92.28 Thyroid mass | 6 0.06 92.34 Thyroidectomy | 2 0.02 92.36 Thyroxine decreased | 2 0.02 92.38 Thyroxine free decreased | 1 0.01 92.39 Thyroxine free increased | 2 0.02 92.41 Tibia fracture | 3 0.03 92.44 Tic | 3 0.03 92.47 Time perception altered | 1 0.01 92.48 Tinea pedis | 1 0.01 92.49 Tinnitus | 6 0.06 92.55 Toe walking | 1 0.01 92.56 Tongue pruritus | 1 0.01 92.57 Tonsillectomy | 5 0.05 92.62 Tonsillitis | 1 0.01 92.63 Tooth disorder | 5 0.05 92.68 Tooth extraction | 4 0.04 92.72 Tooth fracture | 2 0.02 92.74 Tooth impacted | 1 0.01 92.75 Tooth infection | 1 0.01 92.76 Tooth injury | 2 0.02 92.78 Toothache | 6 0.06 92.84 Torsade de pointes | 1 0.01 92.85 Torticollis | 1 0.01 92.86 Total lung capacity decreased | 3 0.03 92.89 Tourette's disorder | 1 0.01 92.90 Toxic epidermal necrolysis | 1 0.01 92.91 Toxic skin eruption | 1 0.01 92.92 Toxicity to various agents | 14 0.14 93.06 Transaminases increased | 2 0.02 93.08 Transfusion reaction | 1 0.01 93.09 Transient ischaemic attack | 8 0.08 93.17 Transplant failure | 1 0.01 93.18 Transplant rejection | 2 0.02 93.20 Traumatic fracture | 1 0.01 93.21 Treatment failure | 3 0.03 93.24 Treatment noncompliance | 5 0.05 93.29 Tremor | 16 0.16 93.45 Trichoglossia | 1 0.01 93.46 Tricuspid valve incompetence | 3 0.03 93.49 Trigeminal neuralgia | 1 0.01 93.50 Trigger finger | 3 0.03 93.53 Trismus | 2 0.02 93.55 Trisomy 21 | 2 0.02 93.57 Troponin increased | 1 0.01 93.58 Tubal rupture | 1 0.01 93.59 Tubulointerstitial nephritis | 1 0.01 93.60 Tumour flare | 2 0.02 93.62 Tumour haemorrhage | 1 0.01 93.63 Tumour lysis syndrome | 5 0.05 93.68 Tumour pain | 1 0.01 93.69 Turner's syndrome | 2 0.02 93.71 Tympanic membrane perforation | 1 0.01 93.72 Type 1 diabetes mellitus | 1 0.01 93.73 Type 2 diabetes mellitus | 7 0.07 93.80 Type I hypersensitivity | 1 0.01 93.81 Type IIa hyperlipidaemia | 1 0.01 93.82 Type V hyperlipidaemia | 1 0.01 93.83 Uhthoff's phenomenon | 1 0.01 93.84 Ulcer | 3 0.03 93.87 Ulcer haemorrhage | 1 0.01 93.88 Ulna fracture | 1 0.01 93.89 Umbilical hernia | 1 0.01 93.90 Umbilical hernia, obstructive | 1 0.01 93.91 Underdose | 4 0.04 93.95 Underweight | 1 0.01 93.96 Unevaluable event | 7 0.07 94.03 Unintended pregnancy | 1 0.01 94.04 Unresponsive to stimuli | 2 0.02 94.06 Upper gastrointestinal haemorrhage | 6 0.06 94.12 Upper limb fracture | 4 0.04 94.16 Upper respiratory tract congestion | 1 0.01 94.17 Upper respiratory tract infection | 19 0.19 94.36 Upper-airway cough syndrome | 3 0.03 94.39 Ureterolithiasis | 1 0.01 94.40 Urethral stenosis | 1 0.01 94.41 Urge incontinence | 1 0.01 94.42 Urinary incontinence | 12 0.12 94.54 Urinary retention | 7 0.07 94.61 Urinary retention postoperative | 1 0.01 94.62 Urinary tract infection | 38 0.38 95.00 Urinary tract infection bacterial | 1 0.01 95.01 Urinary tract infection enterococcal | 1 0.01 95.02 Urinary tract obstruction | 1 0.01 95.03 Urinary tract pain | 1 0.01 95.04 Urine abnormality | 1 0.01 95.05 Urine ketone body present | 1 0.01 95.06 Urine odour abnormal | 2 0.02 95.08 Urine output decreased | 2 0.02 95.10 Urogenital atrophy | 1 0.01 95.11 Urticaria | 14 0.14 95.25 Uterine disorder | 5 0.05 95.30 Uterine haemorrhage | 1 0.01 95.31 Uterine perforation | 6 0.06 95.37 Uterine prolapse | 2 0.02 95.39 Uterovaginal prolapse | 1 0.01 95.40 Uveitis | 2 0.02 95.42 VIth nerve paralysis | 2 0.02 95.44 Vaccination failure | 2 0.02 95.46 Vaginal discharge | 2 0.02 95.48 Vaginal haemorrhage | 7 0.07 95.55 Vaginal prolapse | 1 0.01 95.56 Varicella | 2 0.02 95.58 Varicose vein | 3 0.03 95.61 Vascular compression | 1 0.01 95.62 Vascular dementia | 1 0.01 95.63 Vascular injury | 1 0.01 95.64 Vascular insufficiency | 1 0.01 95.65 Vascular occlusion | 1 0.01 95.66 Vascular resistance systemic | 1 0.01 95.67 Vascular stenosis | 1 0.01 95.68 Vascular stent thrombosis | 1 0.01 95.69 Vasculitis | 5 0.05 95.74 Vasculitis cerebral | 1 0.01 95.75 Vasodilatation | 2 0.02 95.77 Vein disorder | 1 0.01 95.78 Vein rupture | 1 0.01 95.79 Venoocclusive disease | 1 0.01 95.80 Venous occlusion | 1 0.01 95.81 Venous thrombosis | 1 0.01 95.82 Venous thrombosis limb | 2 0.02 95.84 Ventricular arrhythmia | 1 0.01 95.85 Ventricular extrasystoles | 3 0.03 95.88 Ventricular fibrillation | 6 0.06 95.94 Ventricular tachycardia | 2 0.02 95.96 Vertebroplasty | 1 0.01 95.97 Vertigo | 7 0.07 96.04 Vertigo positional | 1 0.01 96.05 Very low density lipoprotein increased | 1 0.01 96.06 Vesicoureteral reflux surgery | 1 0.01 96.07 Vibration test abnormal | 1 0.01 96.08 Victim of homicide | 1 0.01 96.09 Violence-related symptom | 1 0.01 96.10 Viral infection | 10 0.10 96.20 Viral load increased | 1 0.01 96.21 Viral sinusitis | 1 0.01 96.22 Viral upper respiratory tract infection | 2 0.02 96.24 Virologic failure | 1 0.01 96.25 Visceral congestion | 2 0.02 96.27 Vision blurred | 18 0.18 96.45 Visual acuity reduced | 7 0.07 96.52 Visual field defect | 1 0.01 96.53 Visual impairment | 26 0.26 96.79 Vitamin B complex deficiency | 1 0.01 96.80 Vitamin B1 decreased | 1 0.01 96.81 Vitamin B12 decreased | 1 0.01 96.82 Vitamin B12 deficiency | 4 0.04 96.86 Vitamin B12 increased | 1 0.01 96.87 Vitamin D decreased | 8 0.08 96.95 Vitamin D deficiency | 12 0.12 97.07 Vitrectomy | 1 0.01 97.08 Vitreous detachment | 1 0.01 97.09 Vitreous floaters | 1 0.01 97.10 Vocal cord disorder | 1 0.01 97.11 Vocal cord neoplasm | 1 0.01 97.12 Vomiting | 69 0.69 97.81 Vomiting projectile | 3 0.03 97.84 Vulvovaginal adhesion | 1 0.01 97.85 Vulvovaginal inflammation | 1 0.01 97.86 Vulvovaginal pain | 1 0.01 97.87 Walking aid user | 4 0.04 97.91 Weight decreased | 64 0.64 98.55 Weight fluctuation | 4 0.04 98.59 Weight gain poor | 3 0.03 98.62 Weight increased | 50 0.50 99.12 Wernicke's encephalopathy | 1 0.01 99.13 West Nile viral infection | 1 0.01 99.14 Wheelchair user | 4 0.04 99.18 Wheezing | 14 0.14 99.32 White blood cell count abnormal | 1 0.01 99.33 White blood cell count decreased | 14 0.14 99.47 White blood cell count increased | 7 0.07 99.54 White matter lesion | 1 0.01 99.55 Withdrawal syndrome | 4 0.04 99.59 Wound | 8 0.08 99.67 Wound abscess | 1 0.01 99.68 Wound complication | 1 0.01 99.69 Wound dehiscence | 1 0.01 99.70 Wound haemorrhage | 1 0.01 99.71 Wound infection | 2 0.02 99.73 Wound infection pseudomonas | 1 0.01 99.74 Wound secretion | 1 0.01 99.75 Wrist deformity | 1 0.01 99.76 Wrist fracture | 6 0.06 99.82 Wrong drug administered | 1 0.01 99.83 Wrong patient received medication | 1 0.01 99.84 Wrong technique in product usage proc.. | 14 0.14 99.98 X-ray abnormal | 1 0.01 99.99 Yellow fever | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Jun 2018